≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback
info icon

Malignant neoplasm of other and unspecified major salivary glands, including Hilmo

Endpoint Browser

C3_SALIVARYNAS_WIDE

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C08
  • Hospital discharge: ICD-9 — 142
  • Hospital discharge: ICD-8 — 142
  • Cause of death: ICD-10 — C08
  • Cause of death: ICD-9 — 142
  • Cause of death: ICD-8 — 142
  • Cause of death: excluded ICD-9 — 1420
  • Cancer registry: Topography ICD-O-3 — C08
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 3

3 out of 7 registries used, show all original rules.

290

4. Check minimum number of events

None

290

5. Include endpoints

None

290

6. Filter based on genotype QC (FinnGen only)

281

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze
DF12

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 281 130 151
Unadjusted period prevalence (%) 0.06 0.05 0.07
Median age at first event (years) 62.82 58.65 66.40

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
290
Matched controls
2900
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
EP1AE
NOMESCO Finland
Neck ultrasound examination
28.8
130.1
96
49
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
48.2
116.0
70
19
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
21.5
87.8
71
43
130
Kela drug reimbursment
Malignant tumour
+∞
86.9
79
*
XX3DW
NOMESCO Finland
Time consuming IT work
16.3
81.2
77
63
ELB40
NOMESCO Finland
Partial parotidectomy
49.5
77.7
46
11
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
73.1
67
*
WZC00
NOMESCO Finland
Treatment plan or consultation
7.9
69.7
177
482
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
18.1
63.9
55
37
ELB30
NOMESCO Finland
Excision of submandibular gland
250.9
60.6
60
*
C08.09
ICD-10 Finland
Malignant tumor of the submandibular or submaxillary gland, other or unspecified histology
+∞
60.6
56
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
20.6
55.2
44
25
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
+∞
53.9
50
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
50.5
47
*
A03FA01
ATC
metoclopramide; systemic, rectal
6.9
49.5
98
200
C08.89
ICD-10 Finland
Malignant overall tumor the large salivary glands anna or unspecified histology
+∞
48.3
45
*
C07.70
ICD-10 Finland
Malignant tumor of the superficial part of the parotid gland
+∞
47.2
44
*
H02AB02
ATC
dexamethasone; systemic
70.0
46.1
52
9
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
114.6
45.3
48
5
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
265.1
45.3
45
*
ELB50
NOMESCO Finland
Total parotidectomy
231.0
39.9
40
*
D11.70
ICD-10 Finland
Gland sublingual
158.5
39.9
41
*
C08.99
ICD-10 Finland
Malignant tumor of unspecified large salivary gland, other or unspecified histology
+∞
38.4
36
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
38.4
36
*
D37.00
ICD-10 Finland
Aryepiglottic fold marginal zone
140.8
35.6
37
*
Z51.5
ICD-10 Finland
Palliative care
9.0
35.1
47
61
N02AA05
ATC
oxycodone; systemic
4.8
32.6
96
270
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
30.8
29
*
C08.90
ICD-10 Finland
Malignant tumor in unspecified large salivary gland without histology
+∞
30.8
29
*
A04AA02
ATC
granisetron; systemic, transdermal
335.5
30.4
30
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
335.5
30.4
30
*
C08.02
ICD-10 Finland
Cystic adenocarcinoma of the submandibular or submaxillary glands
+∞
29.7
28
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
322.6
29.3
29
*
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
166.6
29.2
30
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
28.6
27
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
111.1
28.2
30
*
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
8.9
27.9
37
47
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
27.5
26
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
107.0
27.2
29
*
WF002
NOMESCO Finland
Radical radiotherapy
107.0
27.2
29
*
JN4BD
NOMESCO Finland
Extensive body CT
7.7
27.1
41
61
A07AA02
ATC
nystatin; oral
6.8
26.5
45
76
C08.00
ICD-10 Finland
Malignant tumor of submandibular or submaxillary gland, not histology
+∞
26.5
25
*
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
10.6
25.4
29
30
EL4AT
NOMESCO Finland
Salivary gland cytology with ultrasound guidance
98.9
25.1
27
*
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
47.6
25.1
30
7
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
272.5
25.1
25
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
142.2
25.0
26
*
8200/3-C08.0
ICD-O-3
Adenoid cystic carcinoma of submandibular gland
+∞
24.3
23
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
24.3
23
*
L03AA13
ATC
pegfilgrastim; parenteral
260.6
24.0
24
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
248.8
23.0
23
*
C08.94
ICD-10 Finland
Mucoepidermoid carcinoma of an unspecified large salivary gland
+∞
22.2
21
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.5
21.7
104
400
WZC30
NOMESCO Finland
Teaching
4.2
21.3
67
193
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
21.1
20
*
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
225.5
20.9
21
*
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
45.4
20.8
25
6
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
62.2
20.2
23
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
20.0
19
*
C07.71
ICD-10 Finland
Malignant tumor in the deep part of the parotid gland
+∞
19.0
18
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
19.0
18
*
SAA03
NOMESCO Finland
Extended examination of mouth
3.0
18.2
139
688
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
56.3
18.2
21
*
JN4AD
NOMESCO Finland
Body CT examination
5.7
18.2
36
70
EBA10
NOMESCO Finland
Operative extraction of tooth
4.3
18.2
54
148
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
17.9
17
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
17.9
17
*
C08.0
ICD-10 Finland
Malignant neoplasm: Submandibular gland
+∞
17.9
17
*
JN6AD
NOMESCO Finland
CT of torso and neck
37.5
16.9
21
6
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
16.8
16
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
16.8
16
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
16.8
16
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
179.9
16.7
17
*
A04AA01
ATC
ondansetron; systemic, rectal
12.8
15.9
28
24
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
3.5
15.8
63
211
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
+∞
15.8
15
*
PJD91
NOMESCO Finland
Excision of lymph nodes in neck, 1 to 2 areas in total
+∞
15.8
15
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
15.8
15
*
L02BB03
ATC
bicalutamide; oral
+∞
15.8
15
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
168.7
15.6
16
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
15.1
15.3
25
18
ZX120
NOMESCO Finland
Intravenous
4.7
15.3
38
90
ZXE30
NOMESCO Finland
More than five and less than seven hours
6.7
15.3
25
40
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
14.7
14
*
EJB30
NOMESCO Finland
Excision of tumor or other lesion of floor of the mouth
+∞
14.7
14
*
C08.01
ICD-10 Finland
Diverse adenocarcinoma of the mandibular salivary gland
+∞
14.7
14
*
R4190
NOMESCO Finland
Nutritional therapy
12.3
14.6
26
23
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
157.6
14.6
15
*
L03AA02
ATC
filgrastim; parenteral
157.6
14.6
15
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.6
14.4
139
755
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
5.9
14.3
27
50
WX402
NOMESCO Finland
General anaesthesia
3.1
14.2
75
297
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
31.8
14.0
18
6
XW000
NOMESCO Finland
Bone marrow biopsy
13.0
13.9
24
20
115
Kela drug reimbursment
Breast cancer
+∞
13.6
13
*
C08.91
ICD-10 Finland
Adenocarcinoma of mixed cell type in unspecified large salivary gland
+∞
13.6
13
*
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
13.6
13
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
13.6
13
*
ZZR00
NOMESCO Finland
Flap of skin
146.6
13.6
14
*
CBK11
NOMESCO Finland
Operation for lagophtalmus with implant
146.6
13.6
14
*
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
5.4
13.2
27
54
R13
ICD-10 Finland
Dysphagia
4.0
12.9
40
112
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
12.6
12
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
12.6
12
*
C07
ICD-10 Finland
Malignant neoplasm of parotid gland
+∞
12.6
12
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
12.6
12
*
EBA15
NOMESCO Finland
Extraction of multiple teeth
5.7
12.5
24
45
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
6.2
12.5
22
38
ZZA00
NOMESCO Finland
Split skin graft
9.6
12.0
24
27
ZXE20
NOMESCO Finland
More than three and less than five hours
3.2
12.0
53
188
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
5.9
11.8
22
40
GBB00
NOMESCO Finland
Tracheostomy
17.3
11.8
18
11
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
67.8
11.7
13
*
8550/3-C07.9
ICD-O-3
Acinar cell carcinoma of parotid gland
+∞
11.5
11
*
8070/3-C07.9
ICD-O-3
Squamous cell carcinoma, NOS, of parotid gland
+∞
11.5
11
*
116
Kela drug reimbursment
Prostate cancer
+∞
11.5
11
*
9699/3-C08.0
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of submandibular gland
+∞
11.5
11
*
PJA10
NOMESCO Finland
Exploration of lymph nodes
29.3
10.8
14
5
G51.0
ICD-10 Finland
Bell palsy
8.7
10.5
22
27
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
12.7
10.5
18
15
4405
FHL
Partial removal of the parotid gland
114.0
10.5
11
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
114.0
10.5
11
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.7
10.5
25
57
A79
ICPC
Malignancy NOS
+∞
10.5
10
*
8200/3-C07.9
ICD-O-3
Adenoid cystic carcinoma of parotid gland
+∞
10.5
10
*
C08.92
ICD-10 Finland
Coastal adenocarcinoma of unspecified salivary gland
+∞
10.5
10
*
C08.80
ICD-10 Finland
Malignant overall tumor of the large salivary glands without histology
+∞
10.5
10
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
10.5
10
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
10.5
10
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
10.5
10
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
10.5
10
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
+∞
10.5
10
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
10.5
10
*
SPF20
NOMESCO Finland
Temporary relining of dentures
33.9
10.4
13
*
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
3.7
10.4
35
104
SAA04
NOMESCO Finland
Special examination of mouth
4.5
9.8
25
60
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
4.6
9.8
24
56
K11.2
ICD-10 Finland
Sialoadenitis
5.3
9.7
20
40
4403
FHL
Submandibular gland removal
56.9
9.7
11
*
WW500
NOMESCO Finland
Blood transfusion
10.6
9.7
18
18
ZXE40
NOMESCO Finland
More than seven and less than nine hours
12.9
9.5
16
13
L02AE02
ATC
leuprorelin; implant, parenteral
31.2
9.5
12
*
K11.70
ICD-10 Finland
Hypoptyalism
103.3
9.5
10
*
SBB00
NOMESCO Finland
Clinical photography of mouth and teeth
9.2
9.4
19
22
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
9.4
9
*
SPA20
NOMESCO Finland
Selection and insertion of implant abutment
+∞
9.4
9
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
9.4
9
*
14201
ICD-8 Finland
Malignant neoplasm of salivary gland, Parotid gland
+∞
9.4
9
*
C08.9
ICD-10 Finland
Malignant neoplasm: Major salivary gland, unspecified
+∞
9.4
9
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
9.4
9
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
9.4
9
*
GD1AD
NOMESCO Finland
Thorax CT examination
4.0
9.0
26
69
ZXE10
NOMESCO Finland
More than one and less than three hours
2.2
9.0
112
650
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
51.6
8.7
10
*
SBB10
NOMESCO Finland
Dental impressions
4.1
8.7
25
66
EBB10
NOMESCO Finland
Insertion of dental implant
12.1
8.7
15
13
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.5
8.6
31
96
K05.30
ICD-10 Finland
Periodontitis complex
2.5
8.6
60
270
EBB15
NOMESCO Finland
Insertion of dental implant abutment
20.8
8.5
12
6
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
3.2
8.5
36
124
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
13.3
8.5
14
11
EHB00
NOMESCO Finland
Excision of lesion of palate
92.6
8.5
9
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
92.6
8.5
9
*
WX707
NOMESCO Finland
Fiberoscopic intubation
+∞
8.4
8
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
8.4
8
*
EP1CM
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with 3 Tesla magnet
+∞
8.4
8
*
8500/3-C07.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of parotid gland
+∞
8.4
8
*
PJD51
NOMESCO Finland
Block dissection of cervical lymph nodes
+∞
8.4
8
*
8430/3-C08.0
ICD-O-3
Mucoepidermoid carcinoma of submandibular gland
+∞
8.4
8
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
8.4
8
*
ELB00
NOMESCO Finland
Excision or exploration of lesion of salivary gland
+∞
8.4
8
*
A04AD12
ATC
aprepitant; systemic
+∞
8.4
8
*
C08.19
ICD-10 Finland
Malignant tumor of the sublingual gland, other or unspecified histology
+∞
8.4
8
*
K08.2
ICD-10 Finland
Atrophy of edentulous alveolar ridge
12.2
8.2
14
12
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.5
8.0
29
90
EP1BG
NOMESCO Finland
MRI examination of soft tissue of neck with high intesity magnet
46.2
7.8
9
*
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
25.8
7.6
10
*
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
82.1
7.5
8
*
EP3AT
NOMESCO Finland
Neck soft tissue biopsy with ultrasound guidance
82.1
7.5
8
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
82.1
7.5
8
*
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
11.3
7.4
13
12
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
9.7
7.4
14
15
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
7.3
7
*
D77
ICPC
Malignant digestive neopl other/NOS
+∞
7.3
7
*
C08.10
ICD-10 Finland
Malignant neoplasm of sublingual gland
+∞
7.3
7
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
7.3
7
*
AAH50
NOMESCO Finland
Cranial nerve anastomosis
+∞
7.3
7
*
2102A
ICD-9 Finland
Benign neoplasm of lip, oral cavity and pharynx, Major salivary glands
+∞
7.3
7
*
C05.1
ICD-10 Finland
Malignant neoplasm: Soft palate
+∞
7.3
7
*
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
+∞
7.3
7
*
XX1AD
NOMESCO Finland
Other CT-examination
+∞
7.3
7
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
7.3
7
*
8200/3-C08.9
ICD-O-3
Adenoid cystic carcinoma of major salivary gland, NOS
+∞
7.3
7
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
7.3
7
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
7.3
7
*
ED1AA
NOMESCO Finland
Mandibular X-ray examination
30.8
7.2
9
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
30.8
7.2
9
*
SXB00
NOMESCO Finland
Removal of sutures from oral mucosa
3.2
7.2
29
97
R50.9
ICD-10 Finland
Fever, unspecified
2.5
7.0
50
226
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prosthodontic work
3.9
7.0
21
57
SHA03
NOMESCO Finland
Stomatognathic treatment, demanding
6.1
7.0
18
31
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.2
7.0
28
93
L02BG04
ATC
letrozole; oral
14.2
6.9
11
8
SBA00
NOMESCO Finland
Microbiological examinations
7.5
6.8
15
21
UDH02
NOMESCO Finland
Rhinopharyngoscopy
3.3
6.8
26
84
SCA04
NOMESCO Finland
Guidance on care of mouth and oral mucosa
23.1
6.7
9
*
UJC01
NOMESCO Finland
Scopy of lower throat
12.6
6.6
11
9
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
71.4
6.5
7
*
SPA10
NOMESCO Finland
Setting attachments on tooth or implanted bracket or imblant based structures
71.4
6.5
7
*
SPAT1153
SPAT
Removal of sutures
2.0
6.4
96
583
SPF30
NOMESCO Finland
Relining of denture
6.8
6.4
15
23
WX110
NOMESCO Finland
Infiltration anesthesia
1.9
6.3
196
1505
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
6.3
144
1003
XX2RW, ,
NOMESCO Finland
18.5
6.3
9
5
C09.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of tonsil
+∞
6.3
6
*
TJD20
NOMESCO Finland
Change of gastrostomy tube
+∞
6.3
6
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
6.3
6
*
K10.26
ICD-10 Finland
Periostitis of jaw (acute)(chronic)(suppurative)
+∞
6.3
6
*
WZC15, ,
NOMESCO Finland
+∞
6.3
6
*
QAB05
NOMESCO Finland
Revision of wound of skin of head or neck
+∞
6.3
6
*
8430/3-C07.9
ICD-O-3
Mucoepidermoid carcinoma of parotid gland
+∞
6.3
6
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
6.3
6
*
8140/3-C08.0
ICD-O-3
Adenocarcinoma, NOS, of submandibular gland
+∞
6.3
6
*
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
+∞
6.3
6
*
WF090
NOMESCO Finland
Profylactic radiotherapy
+∞
6.3
6
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
6.3
6
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
27.3
6.3
8
*
K11.9
ICD-10 Finland
Disease of salivary gland, unspecified
27.3
6.3
8
*
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
8.9
6.1
12
14
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
2.0
6.1
81
471
SCA02
NOMESCO Finland
Preventive oral health care
2.8
6.0
31
119

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Otolaryngology
4 [38004449]
1.1e+00
2.9e+00
5.1e+00
1.0e+50
5.5e+00
4.5e+00
3.1e+00
cases:24.73%
controls:9.63%
cases:44.00%
controls:4.23%
cases:48.36%
controls:0.58%
cases:62.18%
controls:0.00%
cases:63.37%
controls:0.73%
cases:77.56%
controls:3.85%
cases:72.99%
controls:11.02%
68
264
207
2478
121
116
154
2626
133
16
142
2726
171
0
104
2742
173
20
100
2715
197
103
57
2572
154
259
57
2091
Outpatient Visit
OP [9202]
8.1e-02
1.0e+00
2.2e+00
5.5e+00
2.5e+00
1.8e+00
1.2e+00
cases:70.18%
controls:68.45%
cases:70.55%
controls:46.13%
cases:45.09%
controls:8.61%
cases:48.00%
controls:0.36%
cases:54.95%
controls:9.47%
cases:83.86%
controls:46.39%
cases:91.00%
controls:75.96%
193
1877
82
865
194
1265
81
1477
124
236
151
2506
132
10
143
2732
150
259
123
2476
213
1241
41
1434
192
1785
19
565
Dentistry
C5 [903277]
1.5e+00
2.9e+00
—
1.0e+50
—
4.5e+00
2.8e+00
cases:5.82%
controls:1.35%
cases:6.55%
controls:0.40%
—
—
cases:4.00%
controls:0.00%
—
—
cases:24.80%
controls:0.37%
cases:20.85%
controls:1.53%
16
37
259
2705
18
11
257
2731
—
11
0
264
2742
—
63
10
191
2665
44
36
167
2314
Outpatient Hospital
22 [8756]
3.0e-01
1.4e+00
3.1e+00
—
3.8e+00
2.0e+00
7.3e-01
cases:28.73%
controls:23.05%
cases:23.27%
controls:6.71%
cases:15.64%
controls:0.84%
—
—
cases:26.01%
controls:0.77%
cases:31.10%
controls:6.02%
cases:30.81%
controls:17.62%
79
632
196
2110
64
184
211
2558
43
23
232
2719
—
71
21
202
2714
79
161
175
2514
65
414
146
1936
Panorama tomography of teeth and jaws or similar X-ray examination
EB1HA [2001301913]
2.4e-01
1.2e+00
2.8e+00
1.0e+50
3.5e+00
2.2e+00
6.4e-01
cases:8.00%
controls:6.38%
cases:5.45%
controls:1.68%
cases:4.00%
controls:0.26%
cases:4.73%
controls:0.00%
cases:6.96%
controls:0.22%
cases:11.02%
controls:1.31%
cases:12.80%
controls:7.15%
22
175
253
2567
15
46
260
2696
11
7
264
2735
13
0
262
2742
19
6
254
2729
28
35
226
2640
27
168
184
2182
Inpatient Visit
IP [9201]
4.7e-01
1.1e+00
2.5e+00
—
3.4e+00
1.8e+00
5.8e-01
cases:10.18%
controls:6.60%
cases:7.64%
controls:2.81%
cases:4.00%
controls:0.33%
—
—
cases:9.16%
controls:0.33%
cases:14.57%
controls:2.65%
cases:14.69%
controls:8.77%
28
181
247
2561
21
77
254
2665
11
9
264
2733
—
25
9
248
2726
37
71
217
2604
31
206
180
2144
Inpatient Hospital
21 [8717]
2.6e-01
1.1e+00
2.3e+00
—
3.0e+00
1.5e+00
6.9e-01
cases:36.36%
controls:30.60%
cases:26.91%
controls:10.69%
cases:16.00%
controls:1.82%
—
—
cases:26.01%
controls:1.68%
cases:34.65%
controls:10.50%
cases:37.91%
controls:23.36%
100
839
175
1903
74
293
201
2449
44
50
231
2692
—
71
46
202
2689
88
281
166
2394
80
549
131
1801
Thorax X-ray examination
GD1AA [2001303617]
2.7e-01
1.2e+00
2.8e+00
—
2.1e+00
1.4e+00
1.1e+00
cases:9.09%
controls:7.11%
cases:8.73%
controls:2.88%
cases:3.64%
controls:0.22%
—
—
cases:4.76%
controls:0.59%
cases:8.66%
controls:2.32%
cases:21.80%
controls:8.51%
25
195
250
2547
24
79
251
2663
10
6
265
2736
—
13
16
260
2719
22
62
232
2613
46
200
165
2150
More than one and less than three hours
ZXE10 [2001311401]
5.4e-01
1.9e+00
2.8e+00
—
—
2.7e+00
1.1e+00
cases:8.36%
controls:5.03%
cases:7.27%
controls:1.13%
cases:2.91%
controls:0.18%
—
—
—
—
cases:10.24%
controls:0.79%
cases:9.00%
controls:3.06%
23
138
252
2604
20
31
255
2711
8
5
267
2737
—
—
26
21
228
2654
19
72
192
2278
Treatment plan or consultation
WZC00 [2001310885]
1.0e+00
2.2e+00
—
1.0e+50
—
3.5e+00
1.6e+00
cases:8.36%
controls:3.10%
cases:6.18%
controls:0.69%
—
—
cases:4.73%
controls:0.00%
—
—
cases:27.56%
controls:1.16%
cases:18.96%
controls:4.51%
23
85
252
2657
17
19
258
2723
—
13
0
262
2742
—
70
31
184
2644
40
106
171
2244
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
8.0e-01
2.6e+00
—
—
—
3.8e+00
1.7e+00
cases:3.27%
controls:1.50%
cases:4.36%
controls:0.33%
—
—
—
—
—
—
cases:16.93%
controls:0.45%
cases:8.06%
controls:1.62%
9
41
266
2701
12
9
263
2733
—
—
—
43
12
211
2663
17
38
194
2312
Office Visit
OMOP4822458 [581477]
1.3e-01
1.0e+00
1.7e+00
—
3.2e+00
2.7e+00
8.9e-01
cases:8.73%
controls:7.73%
cases:5.45%
controls:2.01%
cases:1.82%
controls:0.33%
—
—
cases:6.96%
controls:0.29%
cases:18.50%
controls:1.50%
cases:11.85%
controls:5.23%
24
212
251
2530
15
55
260
2687
5
9
270
2733
—
19
8
254
2727
47
40
207
2635
25
123
186
2227
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
3.6e-01
9.2e-01
1.9e+00
1.0e+50
3.5e+00
1.5e+00
5.7e-01
cases:9.09%
controls:6.49%
cases:8.73%
controls:3.68%
cases:4.00%
controls:0.62%
cases:2.18%
controls:0.00%
cases:10.99%
controls:0.37%
cases:14.96%
controls:3.93%
cases:17.54%
controls:10.77%
25
178
250
2564
24
101
251
2641
11
17
264
2725
6
0
269
2742
30
10
243
2725
38
105
216
2570
37
253
174
2097
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
1.4e-02
7.2e-01
2.9e+00
1.0e+50
3.4e+00
1.5e+00
5.1e-01
cases:6.91%
controls:6.82%
cases:6.18%
controls:3.10%
cases:7.27%
controls:0.44%
cases:2.55%
controls:0.00%
cases:9.16%
controls:0.33%
cases:11.42%
controls:2.84%
cases:14.69%
controls:9.36%
19
187
256
2555
17
85
258
2657
20
12
255
2730
7
0
268
2742
25
9
248
2726
29
76
225
2599
31
220
180
2130
Oral Surgery
19 [38004464]
2.0e+00
2.8e+00
—
—
—
—
2.8e+00
cases:2.18%
controls:0.29%
cases:3.64%
controls:0.22%
—
—
—
—
—
—
—
—
cases:6.64%
controls:0.43%
6
8
269
2734
10
6
265
2736
—
—
—
—
14
10
197
2340
Tissue Pathology biopsy report
66121-5 [40768804]
6.7e-01
1.6e+00
2.8e+00
—
—
2.1e+00
1.2e+00
cases:8.73%
controls:4.67%
cases:8.36%
controls:1.82%
cases:4.00%
controls:0.26%
—
—
—
—
cases:10.63%
controls:1.50%
cases:18.48%
controls:6.34%
24
128
251
2614
23
50
252
2692
11
7
264
2735
—
—
27
40
227
2635
39
149
172
2201
cefalexin; oral
J01DB01 [21602870]
3.5e-01
9.9e-01
2.9e+00
—
2.3e+00
1.3e+00
5.0e-01
cases:33.45%
controls:26.08%
cases:20.36%
controls:8.64%
cases:9.45%
controls:0.58%
—
—
cases:8.06%
controls:0.88%
cases:24.02%
controls:8.00%
cases:35.07%
controls:24.64%
92
715
183
2027
56
237
219
2505
26
16
249
2726
—
22
24
251
2711
61
214
193
2461
74
579
137
1771
Plastic And Reconstructive Surgery
24 [38004467]
1.2e+00
2.0e+00
—
—
—
3.0e+00
2.3e+00
cases:4.36%
controls:1.42%
cases:3.27%
controls:0.47%
—
—
—
—
—
—
cases:7.09%
controls:0.37%
cases:11.37%
controls:1.23%
12
39
263
2703
9
13
266
2729
—
—
—
18
10
236
2665
24
29
187
2321
Immunohistochemistry procedure
117617002 [4035726]
—
1.0e+50
1.0e+50
1.0e+50
1.0e+50
3.6e+00
3.6e+00
—
—
cases:6.55%
controls:0.00%
cases:4.73%
controls:0.00%
cases:7.64%
controls:0.00%
cases:4.40%
controls:0.00%
cases:6.30%
controls:0.19%
cases:7.11%
controls:0.21%
—
18
0
257
2742
13
0
262
2742
21
0
254
2742
12
0
261
2735
16
5
238
2670
15
5
196
2345
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
6.7e-02
4.6e-01
9.9e-01
3.0e+00
2.2e+00
9.5e-01
1.1e-01
cases:27.27%
controls:25.97%
cases:25.09%
controls:17.47%
cases:8.73%
controls:3.43%
cases:4.73%
controls:0.26%
cases:20.15%
controls:2.71%
cases:37.01%
controls:18.47%
cases:39.81%
controls:37.32%
75
712
200
2030
69
479
206
2263
24
94
251
2648
13
7
262
2735
55
74
218
2661
94
494
160
2181
84
877
127
1473
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
4.1e-02
4.0e-01
1.3e+00
3.0e+00
2.0e+00
6.8e-01
2.0e-01
cases:21.09%
controls:20.42%
cases:24.00%
controls:17.51%
cases:12.00%
controls:3.65%
cases:3.64%
controls:0.18%
cases:20.51%
controls:3.44%
cases:33.46%
controls:20.34%
cases:40.76%
controls:36.00%
58
560
217
2182
66
480
209
2262
33
100
242
2642
10
5
265
2737
56
94
217
2641
85
544
169
2131
86
846
125
1504
General anesthesia, balanced
WX408 [2001310808]
7.1e-01
2.5e+00
1.0e+50
—
—
2.9e+00
1.6e+00
cases:5.82%
controls:2.95%
cases:6.18%
controls:0.55%
cases:4.73%
controls:0.00%
—
—
—
—
cases:9.45%
controls:0.60%
cases:7.11%
controls:1.53%
16
81
259
2661
17
15
258
2727
13
0
262
2742
—
—
24
16
230
2659
15
36
196
2314
dexamethasone; oral, parenteral
H02AB02 [21602730]
7.9e-01
2.2e+00
—
—
—
2.9e+00
1.7e+00
cases:2.55%
controls:1.17%
cases:3.64%
controls:0.40%
—
—
—
—
—
—
cases:6.69%
controls:0.41%
cases:9.48%
controls:1.83%
7
32
268
2710
10
11
265
2731
—
—
—
17
11
237
2664
20
43
191
2307
oxycodone; oral, parenteral
N02AA05 [21604260]
1.1e+00
2.0e+00
—
—
—
3.2e+00
1.5e+00
cases:3.27%
controls:1.09%
cases:2.55%
controls:0.36%
—
—
—
—
—
—
cases:14.57%
controls:0.67%
cases:9.00%
controls:2.13%
9
30
266
2712
7
10
268
2732
—
—
—
37
18
217
2657
19
50
192
2300
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
-7.6e-03
3.2e-01
1.3e+00
2.9e+00
1.9e+00
5.9e-01
1.4e-02
cases:32.36%
controls:32.53%
cases:34.18%
controls:27.46%
cases:18.18%
controls:5.94%
cases:5.09%
controls:0.29%
cases:28.94%
controls:5.70%
cases:43.70%
controls:30.06%
cases:49.76%
controls:49.40%
89
892
186
1850
94
753
181
1989
50
163
225
2579
14
8
261
2734
79
156
194
2579
111
804
143
1871
105
1161
106
1189
Hematology
82 [38004501]
1.9e+00
2.2e+00
—
—
—
—
2.6e+00
cases:2.55%
controls:0.40%
cases:2.18%
controls:0.26%
—
—
—
—
—
—
—
—
cases:6.64%
controls:0.51%
7
11
268
2731
6
7
269
2735
—
—
—
—
14
12
197
2338
Leukocytes [#/volume] in Blood
26464-8 [3010813]
6.2e-02
2.9e-01
1.2e+00
3.0e+00
1.8e+00
5.3e-01
-2.9e-02
cases:36.36%
controls:34.94%
cases:36.00%
controls:29.65%
cases:18.91%
controls:6.35%
cases:5.82%
controls:0.29%
cases:27.84%
controls:6.22%
cases:43.70%
controls:31.29%
cases:51.18%
controls:51.91%
100
958
175
1784
99
813
176
1929
52
174
223
2568
16
8
259
2734
76
170
197
2565
111
837
143
1838
108
1220
103
1130
Platelets [#/volume] in Blood
26515-7 [3007461]
4.6e-02
2.9e-01
1.2e+00
3.0e+00
1.8e+00
5.4e-01
-2.6e-02
cases:36.00%
controls:34.94%
cases:36.00%
controls:29.61%
cases:18.55%
controls:6.31%
cases:5.82%
controls:0.29%
cases:27.84%
controls:6.22%
cases:43.70%
controls:31.21%
cases:51.18%
controls:51.83%
99
958
176
1784
99
812
176
1930
51
173
224
2569
16
8
259
2734
76
170
197
2565
111
835
143
1840
108
1218
103
1132
MCH [Entitic mass]
28539-5 [3035941]
4.6e-02
2.8e-01
1.2e+00
3.0e+00
1.8e+00
5.4e-01
-2.9e-02
cases:36.00%
controls:34.94%
cases:35.64%
controls:29.58%
cases:18.55%
controls:6.31%
cases:5.82%
controls:0.29%
cases:27.84%
controls:6.22%
cases:43.70%
controls:31.21%
cases:51.18%
controls:51.91%
99
958
176
1784
98
811
177
1931
51
173
224
2569
16
8
259
2734
76
170
197
2565
111
835
143
1840
108
1220
103
1130
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
4.8e-02
2.7e-01
1.2e+00
3.0e+00
1.8e+00
5.4e-01
-2.9e-02
cases:36.00%
controls:34.90%
cases:35.64%
controls:29.61%
cases:18.55%
controls:6.31%
cases:5.82%
controls:0.29%
cases:27.84%
controls:6.22%
cases:43.70%
controls:31.25%
cases:51.18%
controls:51.91%
99
957
176
1785
98
812
177
1930
51
173
224
2569
16
8
259
2734
76
170
197
2565
111
836
143
1839
108
1220
103
1130
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
4.6e-02
2.9e-01
1.2e+00
3.0e+00
1.8e+00
5.4e-01
-2.9e-02
cases:36.00%
controls:34.94%
cases:36.00%
controls:29.65%
cases:18.55%
controls:6.31%
cases:5.82%
controls:0.29%
cases:27.84%
controls:6.22%
cases:43.70%
controls:31.25%
cases:51.18%
controls:51.91%
99
958
176
1784
99
813
176
1929
51
173
224
2569
16
8
259
2734
76
170
197
2565
111
836
143
1839
108
1220
103
1130
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
4.3e-02
2.9e-01
1.2e+00
3.0e+00
1.8e+00
5.4e-01
-3.1e-02
cases:36.00%
controls:35.01%
cases:36.00%
controls:29.69%
cases:18.55%
controls:6.27%
cases:5.82%
controls:0.29%
cases:27.84%
controls:6.25%
cases:43.70%
controls:31.25%
cases:51.18%
controls:51.96%
99
960
176
1782
99
814
176
1928
51
172
224
2570
16
8
259
2734
76
171
197
2564
111
836
143
1839
108
1221
103
1129
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
4.5e-02
2.9e-01
1.2e+00
3.0e+00
1.8e+00
5.4e-01
-2.6e-02
cases:36.00%
controls:34.97%
cases:36.00%
controls:29.65%
cases:18.55%
controls:6.35%
cases:5.82%
controls:0.29%
cases:27.84%
controls:6.22%
cases:43.70%
controls:31.25%
cases:51.18%
controls:51.83%
99
959
176
1783
99
813
176
1929
51
174
224
2568
16
8
259
2734
76
170
197
2565
111
836
143
1839
108
1218
103
1132
Telephone, letter or other consultation without direct patient contact
ZY020 [2001311600]
1.0e+00
—
—
—
—
3.4e+00
3.2e+00
cases:1.82%
controls:0.66%
—
—
—
—
—
—
—
—
cases:5.12%
controls:0.19%
cases:6.64%
controls:0.30%
5
18
270
2724
—
—
—
—
13
5
241
2670
14
7
197
2343
Loss of teeth due to accident, extraction or local periodontal disease
K08.1 [45591573]
1.4e+00
1.9e+00
—
1.0e+50
—
2.8e+00
1.8e+00
cases:3.64%
controls:0.95%
cases:2.55%
controls:0.40%
—
—
cases:2.18%
controls:0.00%
—
—
cases:7.09%
controls:0.45%
cases:10.90%
controls:1.96%
10
26
265
2716
7
11
268
2731
—
6
0
269
2742
—
18
12
236
2663
23
46
188
2304
Infiltration anesthesia
WX110 [2001310767]
5.8e-02
7.2e-01
2.0e+00
—
1.9e+00
1.3e+00
6.3e-01
cases:17.45%
controls:16.63%
cases:11.27%
controls:5.80%
cases:5.45%
controls:0.80%
—
—
cases:6.23%
controls:1.02%
cases:18.50%
controls:5.76%
cases:29.38%
controls:18.09%
48
456
227
2286
31
159
244
2583
15
22
260
2720
—
17
28
256
2707
47
154
207
2521
62
425
149
1925
Other specified counselling
Z71.8 [45581061]
5.0e-02
1.1e+00
2.7e+00
—
2.3e+00
1.4e+00
4.9e-02
cases:2.91%
controls:2.77%
cases:4.36%
controls:1.46%
cases:3.27%
controls:0.22%
—
—
cases:2.20%
controls:0.22%
cases:6.30%
controls:1.64%
cases:6.64%
controls:6.34%
8
76
267
2666
12
40
263
2702
9
6
266
2736
—
6
6
267
2729
16
44
238
2631
14
149
197
2201
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
1.5e-01
5.4e-01
2.0e+00
—
3.1e+00
1.3e+00
6.9e-01
cases:4.00%
controls:3.46%
cases:3.27%
controls:1.93%
cases:2.18%
controls:0.29%
—
—
cases:4.03%
controls:0.18%
cases:6.69%
controls:1.98%
cases:9.95%
controls:5.28%
11
95
264
2647
9
53
266
2689
6
8
269
2734
—
11
5
262
2730
17
53
237
2622
21
124
190
2226
Laboratory Visit
OMOP4822461 [32036]
1.4e-02
2.5e-01
1.3e+00
3.6e+00
1.6e+00
3.5e-01
-5.7e-02
cases:38.91%
controls:38.58%
cases:42.55%
controls:36.47%
cases:32.73%
controls:11.67%
cases:19.64%
controls:0.69%
cases:37.00%
controls:10.97%
cases:46.85%
controls:38.28%
cases:54.03%
controls:55.45%
107
1058
168
1684
117
1000
158
1742
90
320
185
2422
54
19
221
2723
101
300
172
2435
119
1024
135
1651
114
1303
97
1047
CBC panel - Blood by Automated count
58410-2 [40761511]
-8.4e-02
1.2e-01
1.2e+00
2.9e+00
1.7e+00
5.8e-01
8.1e-02
cases:28.00%
controls:29.72%
cases:23.27%
controls:21.23%
cases:12.36%
controls:3.98%
cases:4.36%
controls:0.26%
cases:17.95%
controls:3.80%
cases:31.10%
controls:20.22%
cases:42.18%
controls:40.21%
77
815
198
1927
64
582
211
2160
34
109
241
2633
12
7
263
2735
49
104
224
2631
79
541
175
2134
89
945
122
1405
nystatin; oral
A07AA02 [21600604]
1.5e+00
—
—
—
—
4.0e+00
2.2e+00
cases:2.91%
controls:0.69%
—
—
—
—
—
—
—
—
cases:11.42%
controls:0.22%
cases:9.00%
controls:1.06%
8
19
267
2723
—
—
—
—
29
6
225
2669
19
25
192
2325
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
-6.9e-02
3.6e-01
1.1e+00
2.9e+00
1.8e+00
4.8e-01
-2.2e-02
cases:29.09%
controls:30.53%
cases:31.27%
controls:24.11%
cases:13.09%
controls:4.60%
cases:4.36%
controls:0.26%
cases:24.18%
controls:5.19%
cases:37.01%
controls:26.62%
cases:45.50%
controls:46.04%
80
837
195
1905
86
661
189
2081
36
126
239
2616
12
7
263
2735
66
142
207
2593
94
712
160
1963
96
1082
115
1268
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
-2.1e-02
3.8e-01
1.1e+00
2.9e+00
1.7e+00
4.7e-01
-2.7e-02
cases:30.55%
controls:31.00%
cases:32.36%
controls:24.62%
cases:13.09%
controls:4.70%
cases:4.36%
controls:0.26%
cases:23.81%
controls:5.27%
cases:37.01%
controls:26.77%
cases:45.97%
controls:46.64%
84
850
191
1892
89
675
186
2067
36
129
239
2613
12
7
263
2735
65
144
208
2591
94
716
160
1959
97
1096
114
1254
dexamethasone and antiinfectives
S03CA01 [21605206]
8.1e-01
1.9e+00
—
—
—
2.9e+00
1.3e+00
cases:4.00%
controls:1.82%
cases:2.55%
controls:0.40%
—
—
—
—
—
—
cases:7.87%
controls:0.45%
cases:8.53%
controls:2.43%
11
50
264
2692
7
11
268
2731
—
—
—
20
12
234
2663
18
57
193
2293
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
-8.9e-02
2.6e-01
9.8e-01
2.7e+00
1.7e+00
5.8e-01
7.6e-02
cases:18.91%
controls:20.31%
cases:20.73%
controls:16.74%
cases:9.45%
controls:3.76%
cases:2.55%
controls:0.18%
cases:15.38%
controls:3.33%
cases:28.35%
controls:18.13%
cases:36.02%
controls:34.30%
52
557
223
2185
57
459
218
2283
26
103
249
2639
7
5
268
2737
42
91
231
2644
72
485
182
2190
76
806
135
1544
Normoblasts [#/volume] in Blood
715-3 [3021589]
3.2e-01
9.8e-01
1.5e+00
—
2.1e+00
1.2e+00
5.8e-01
cases:8.36%
controls:6.20%
cases:10.91%
controls:4.38%
cases:4.73%
controls:1.09%
—
—
cases:5.86%
controls:0.77%
cases:15.35%
controls:5.05%
cases:20.38%
controls:12.51%
23
170
252
2572
30
120
245
2622
13
30
262
2712
—
16
21
257
2714
39
135
215
2540
43
294
168
2056
INR in Blood by Coagulation assay
34714-6 [3032080]
2.1e-01
6.5e-01
1.3e+00
2.2e+00
1.3e+00
9.5e-01
3.9e-01
cases:11.27%
controls:9.34%
cases:10.18%
controls:5.58%
cases:7.64%
controls:2.30%
cases:2.18%
controls:0.26%
cases:8.42%
controls:2.38%
cases:12.99%
controls:5.46%
cases:18.96%
controls:13.70%
31
256
244
2486
28
153
247
2589
21
63
254
2679
6
7
269
2735
23
65
250
2670
33
146
221
2529
40
322
171
2028
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
5.7e-01
1.3e+00
—
—
2.0e+00
1.3e+00
1.0e+00
cases:5.09%
controls:2.95%
cases:5.09%
controls:1.42%
—
—
—
—
cases:2.56%
controls:0.37%
cases:8.27%
controls:2.32%
cases:13.74%
controls:5.36%
14
81
261
2661
14
39
261
2703
—
—
7
10
266
2725
21
62
233
2613
29
126
182
2224
Extended examination of mouth
SAA03 [2001310276]
1.9e-01
1.4e+00
—
1.0e+50
—
2.5e+00
1.6e+00
cases:8.36%
controls:7.04%
cases:4.36%
controls:1.17%
—
—
cases:2.55%
controls:0.00%
—
—
cases:11.42%
controls:1.05%
cases:17.06%
controls:3.96%
23
193
252
2549
12
32
263
2710
—
7
0
268
2742
—
29
28
225
2647
36
93
175
2257
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
4.3e-01
8.3e-01
1.1e+00
—
2.7e+00
1.9e+00
5.6e-01
cases:11.27%
controls:7.62%
cases:8.36%
controls:3.83%
cases:1.82%
controls:0.62%
—
—
cases:6.96%
controls:0.51%
cases:24.02%
controls:4.45%
cases:20.85%
controls:13.11%
31
209
244
2533
23
105
252
2637
5
17
270
2725
—
19
14
254
2721
61
119
193
2556
44
308
167
2042
Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
2039-6 [3003785]
1.1e+00
2.6e+00
—
—
—
2.7e+00
1.4e+00
cases:2.91%
controls:1.02%
cases:2.91%
controls:0.22%
—
—
—
—
—
—
cases:3.94%
controls:0.26%
cases:3.79%
controls:0.94%
8
28
267
2714
8
6
267
2736
—
—
—
10
7
244
2668
8
22
203
2328
Excision of other lesion extending through all layers of skin in head or neck
QAE10 [2001309784]
2.8e+00
—
—
—
—
—
2.6e+00
cases:2.91%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
cases:5.21%
controls:0.43%
8
5
267
2737
—
—
—
—
—
11
10
200
2340
Supplier / Service Provider
OMOP5117446 [33004]
-1.0e+00
-5.9e-01
7.7e-01
—
—
3.1e+00
3.2e+00
cases:11.27%
controls:26.19%
cases:4.36%
controls:7.62%
cases:2.18%
controls:1.02%
—
—
—
—
cases:7.09%
controls:0.34%
cases:17.06%
controls:0.85%
31
718
244
2024
12
209
263
2533
6
28
269
2714
—
—
18
9
236
2666
36
20
175
2330
Physiotherapist
Z3226 [2001311560]
4.6e-01
2.4e+00
—
—
—
2.7e+00
9.6e-01
cases:3.64%
controls:2.33%
cases:3.64%
controls:0.33%
—
—
—
—
—
—
cases:5.91%
controls:0.41%
cases:4.74%
controls:1.87%
10
64
265
2678
10
9
265
2733
—
—
—
15
11
239
2664
10
44
201
2306
Case Management Agency
251B00000X [38004193]
1.4e-02
2.9e-01
7.6e-01
2.9e+00
9.3e-01
4.7e-01
-6.0e-02
cases:59.27%
controls:58.94%
cases:57.45%
controls:50.36%
cases:34.55%
controls:19.84%
cases:18.18%
controls:1.17%
cases:41.03%
controls:21.54%
cases:65.35%
controls:54.17%
cases:71.09%
controls:72.30%
163
1616
112
1126
158
1381
117
1361
95
544
180
2198
50
32
225
2710
112
589
161
2146
166
1449
88
1226
150
1699
61
651
Physiotherapy
R4110 [2001310233]
1.9e-01
6.8e-01
—
—
3.0e+00
2.0e+00
1.3e-01
cases:5.09%
controls:4.23%
cases:3.27%
controls:1.68%
—
—
—
—
cases:5.49%
controls:0.29%
cases:10.24%
controls:1.50%
cases:5.21%
controls:4.60%
14
116
261
2626
9
46
266
2696
—
—
15
8
258
2727
26
40
228
2635
11
108
200
2242
Teaching
WZC30 [2001310891]
8.6e-01
1.9e+00
—
—
—
3.0e+00
9.5e-01
cases:2.55%
controls:1.09%
cases:3.64%
controls:0.58%
—
—
—
—
—
—
cases:10.63%
controls:0.60%
cases:6.16%
controls:2.47%
7
30
268
2712
10
16
265
2726
—
—
—
27
16
227
2659
13
58
198
2292
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
3.7e-01
9.1e-01
1.1e+00
—
1.7e+00
1.5e+00
6.3e-01
cases:13.45%
controls:9.74%
cases:12.36%
controls:5.36%
cases:3.64%
controls:1.28%
—
—
cases:6.23%
controls:1.21%
cases:23.23%
controls:6.09%
cases:24.64%
controls:14.85%
37
267
238
2475
34
147
241
2595
10
35
265
2707
—
17
33
256
2702
59
163
195
2512
52
349
159
2001
Upper gastrointestinal surgery
106 [44777669]
2.8e-01
6.1e-01
—
—
2.7e+00
1.3e+00
7.5e-01
cases:9.82%
controls:7.59%
cases:5.09%
controls:2.84%
—
—
—
—
cases:2.56%
controls:0.18%
cases:8.66%
controls:2.50%
cases:16.59%
controls:8.60%
27
208
248
2534
14
78
261
2664
—
—
7
5
266
2730
22
67
232
2608
35
202
176
2148
amoxicillin; oral, parenteral
J01CA04 [21602823]
3.0e-01
9.5e-01
—
—
2.7e+00
1.0e+00
4.4e-01
cases:22.55%
controls:17.72%
cases:11.27%
controls:4.67%
—
—
—
—
cases:3.66%
controls:0.26%
cases:13.39%
controls:5.16%
cases:26.54%
controls:18.81%
62
486
213
2256
31
128
244
2614
—
—
10
7
263
2728
34
138
220
2537
56
442
155
1908
Laceration/cut
S18 [2002000983]
3.7e-01
8.2e-01
—
—
2.8e+00
1.8e+00
6.8e-01
cases:9.82%
controls:6.97%
cases:5.45%
controls:2.48%
—
—
—
—
cases:4.76%
controls:0.29%
cases:11.81%
controls:2.09%
cases:15.17%
controls:8.34%
27
191
248
2551
15
68
260
2674
—
—
13
8
260
2727
30
56
224
2619
32
196
179
2154
ABO and Rh group [Type] in Blood
882-1 [3003694]
-2.8e-01
1.0e+00
3.2e+00
1.0e+50
—
1.4e+00
-1.8e-01
cases:2.55%
controls:3.36%
cases:3.27%
controls:1.20%
cases:5.09%
controls:0.22%
cases:1.82%
controls:0.00%
—
—
cases:4.33%
controls:1.08%
cases:3.79%
controls:4.51%
7
92
268
2650
9
33
266
2709
14
6
261
2736
5
0
270
2742
—
11
29
243
2646
8
106
203
2244
One hour or less
ZXE00 [2001311394]
6.5e-01
1.2e+00
—
—
—
1.9e+00
1.4e+00
cases:9.82%
controls:5.36%
cases:5.09%
controls:1.64%
—
—
—
—
—
—
cases:5.51%
controls:0.86%
cases:11.85%
controls:3.06%
27
147
248
2595
14
45
261
2697
—
—
—
14
23
240
2652
25
72
186
2278
Chronic apical periodontitis
K04.5 [45586691]
-4.9e-02
8.3e-01
—
—
2.7e+00
1.7e+00
8.0e-01
cases:4.00%
controls:4.19%
cases:2.55%
controls:1.13%
—
—
—
—
cases:3.30%
controls:0.22%
cases:5.12%
controls:0.97%
cases:8.06%
controls:3.79%
11
115
264
2627
7
31
268
2711
—
—
9
6
264
2729
13
26
241
2649
17
89
194
2261
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
2.5e-01
8.3e-01
2.6e+00
—
—
1.8e+00
6.1e-01
cases:5.82%
controls:4.60%
cases:4.73%
controls:2.12%
cases:2.91%
controls:0.22%
—
—
—
—
cases:10.63%
controls:2.02%
cases:10.90%
controls:6.26%
16
126
259
2616
13
58
262
2684
8
6
267
2736
—
—
27
54
227
2621
23
147
188
2203
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
1.2e+00
1.5e+00
2.5e+00
—
—
1.8e+00
1.0e+00
cases:3.27%
controls:1.06%
cases:2.91%
controls:0.69%
cases:2.18%
controls:0.18%
—
—
—
—
cases:4.33%
controls:0.75%
cases:3.79%
controls:1.36%
9
29
266
2713
8
19
267
2723
6
5
269
2737
—
—
11
20
243
2655
8
32
203
2318
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
7.8e-01
1.3e+00
—
—
—
1.2e+00
9.4e-01
cases:9.45%
controls:4.56%
cases:5.82%
controls:1.71%
—
—
—
—
—
—
cases:5.91%
controls:1.79%
cases:13.27%
controls:5.66%
26
125
249
2617
16
47
259
2695
—
—
—
15
48
239
2627
28
133
183
2217
Sedation and analgesia
WX002 [2001310758]
7.5e-01
1.2e+00
—
—
—
2.6e+00
1.6e+00
cases:5.09%
controls:2.48%
cases:2.91%
controls:0.88%
—
—
—
—
—
—
cases:5.51%
controls:0.41%
cases:7.11%
controls:1.57%
14
68
261
2674
8
24
267
2718
—
—
—
14
11
240
2664
15
37
196
2313
Operative extraction of tooth
EBA10 [2001301925]
1.3e+00
2.3e+00
—
—
—
—
1.7e+00
cases:2.91%
controls:0.84%
cases:2.18%
controls:0.22%
—
—
—
—
—
—
—
—
cases:3.79%
controls:0.68%
8
23
267
2719
6
6
269
2736
—
—
—
—
8
16
203
2334
12 lead EKG panel
34534-8 [3044889]
1.2e-01
3.9e-01
1.3e+00
—
1.9e+00
8.1e-01
1.8e-01
cases:18.18%
controls:16.45%
cases:12.36%
controls:8.68%
cases:5.09%
controls:1.50%
—
—
cases:8.79%
controls:1.39%
cases:17.72%
controls:8.75%
cases:27.49%
controls:24.09%
50
451
225
2291
34
238
241
2504
14
41
261
2701
—
24
38
249
2697
45
234
209
2441
58
566
153
1784
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 [3048816]
7.7e-01
1.8e+00
—
—
—
2.1e+00
1.2e+00
cases:2.18%
controls:1.02%
cases:2.55%
controls:0.44%
—
—
—
—
—
—
cases:3.94%
controls:0.49%
cases:4.74%
controls:1.45%
6
28
269
2714
7
12
268
2730
—
—
—
10
13
244
2662
10
34
201
2316
sodium fluoride; oral
A01AA01 [21600005]
—
—
—
—
—
2.1e+00
1.7e+00
—
—
—
—
—
—
—
—
—
—
cases:3.54%
controls:0.45%
cases:5.21%
controls:1.02%
—
—
—
—
—
9
12
245
2663
11
24
200
2326
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
2.7e-01
3.4e-01
1.3e+00
—
1.6e+00
8.8e-01
2.9e-01
cases:36.73%
controls:30.71%
cases:22.91%
controls:17.47%
cases:12.00%
controls:3.54%
—
—
cases:14.29%
controls:3.36%
cases:35.83%
controls:18.77%
cases:45.50%
controls:38.38%
101
842
174
1900
63
479
212
2263
33
97
242
2645
—
39
92
234
2643
91
502
163
2173
96
902
115
1448
Emergency Room Visit
ER [9203]
4.7e-02
5.0e-01
1.7e+00
—
1.2e+00
7.8e-01
4.4e-01
cases:33.45%
controls:32.42%
cases:16.73%
controls:10.87%
cases:8.73%
controls:1.68%
—
—
cases:5.13%
controls:1.57%
cases:19.69%
controls:10.06%
cases:36.97%
controls:27.45%
92
889
183
1853
46
298
229
2444
24
46
251
2696
—
14
43
259
2692
50
269
204
2406
78
645
133
1705
Person consulting for explanation of investigation findings
Z71.2 [45552100]
-3.4e-02
1.4e+00
—
—
2.3e+00
4.6e-01
3.7e-01
cases:3.64%
controls:3.76%
cases:4.73%
controls:1.20%
—
—
—
—
cases:2.20%
controls:0.22%
cases:2.76%
controls:1.76%
cases:6.64%
controls:4.68%
10
103
265
2639
13
33
262
2709
—
—
6
6
267
2729
7
47
247
2628
14
110
197
2240
Caries of dentine
K02.1 [45548134]
3.1e-02
2.7e-01
1.0e+00
—
1.9e+00
1.1e+00
5.7e-01
cases:13.82%
controls:13.46%
cases:8.00%
controls:6.24%
cases:2.55%
controls:0.91%
—
—
cases:5.86%
controls:0.88%
cases:15.75%
controls:5.76%
cases:26.07%
controls:16.64%
38
369
237
2373
22
171
253
2571
7
25
268
2717
—
16
24
257
2711
40
154
214
2521
55
391
156
1959
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
9.3e-01
—
—
—
—
2.3e+00
1.3e+00
cases:2.18%
controls:0.88%
—
—
—
—
—
—
—
—
cases:6.30%
controls:0.67%
cases:7.58%
controls:2.13%
6
24
269
2718
—
—
—
—
16
18
238
2657
16
50
195
2300
Left side
ZXA05 [2001311347]
3.0e-01
1.7e+00
—
1.0e+50
1.0e+50
1.9e+00
9.7e-01
cases:4.36%
controls:3.28%
cases:4.00%
controls:0.77%
—
—
cases:2.91%
controls:0.00%
cases:5.13%
controls:0.00%
cases:5.91%
controls:0.97%
cases:6.16%
controls:2.43%
12
90
263
2652
11
21
264
2721
—
8
0
267
2742
14
0
259
2735
15
26
239
2649
13
57
198
2293
Extraction of tooth
EBA00 [2001301923]
-3.7e-01
1.5e-01
—
—
2.3e+00
1.2e+00
-1.2e-01
cases:4.36%
controls:6.20%
cases:1.82%
controls:1.57%
—
—
—
—
cases:2.93%
controls:0.29%
cases:6.30%
controls:1.98%
cases:6.64%
controls:7.40%
12
170
263
2572
5
43
270
2699
—
—
8
8
265
2727
16
53
238
2622
14
174
197
2176
Basophils [#/volume] in Blood
26444-0 [3006315]
3.3e-01
7.8e-01
9.0e-01
1.0e+50
1.7e+00
1.0e+00
4.7e-01
cases:12.00%
controls:8.94%
cases:10.18%
controls:4.92%
cases:2.91%
controls:1.20%
cases:1.82%
controls:0.00%
cases:4.76%
controls:0.91%
cases:14.17%
controls:5.50%
cases:20.38%
controls:13.83%
33
245
242
2497
28
135
247
2607
8
33
267
2709
5
0
270
2742
13
25
260
2710
36
147
218
2528
43
325
168
2025
Scheduled procedure
ZXD10 [2001311387]
4.7e-01
1.4e+00
2.3e+00
—
—
2.1e+00
9.4e-01
cases:8.73%
controls:5.65%
cases:6.55%
controls:1.68%
cases:1.82%
controls:0.18%
—
—
—
—
cases:8.66%
controls:1.16%
cases:7.58%
controls:3.11%
24
155
251
2587
18
46
257
2696
5
5
270
2737
—
—
22
31
232
2644
16
73
195
2277
Periodontitis complex
K05.30 [2000502728]
—
—
—
—
—
2.3e+00
1.2e+00
—
—
—
—
—
—
—
—
—
—
cases:6.69%
controls:0.71%
cases:7.58%
controls:2.47%
—
—
—
—
—
17
19
237
2656
16
58
195
2292
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
-5.2e-02
6.9e-01
1.1e+00
—
2.3e+00
1.1e+00
2.7e-01
cases:8.00%
controls:8.39%
cases:8.73%
controls:4.56%
cases:1.82%
controls:0.62%
—
—
cases:4.40%
controls:0.44%
cases:12.99%
controls:4.60%
cases:17.54%
controls:14.00%
22
230
253
2512
24
125
251
2617
5
17
270
2725
—
12
12
261
2723
33
123
221
2552
37
329
174
2021
Oncology Clinic/Center
261QX0200X [38004268]
—
—
1.0e+50
1.0e+50
1.0e+50
—
3.4e+00
—
—
—
—
cases:12.00%
controls:0.00%
cases:39.64%
controls:0.00%
cases:10.99%
controls:0.00%
—
—
cases:9.48%
controls:0.34%
—
—
33
0
242
2742
109
0
166
2742
30
0
243
2735
—
20
8
191
2342
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
1.9e-01
4.1e-01
1.3e+00
—
2.2e+00
1.2e+00
2.8e-01
cases:11.27%
controls:9.52%
cases:8.00%
controls:5.47%
cases:3.64%
controls:1.06%
—
—
cases:8.06%
controls:0.95%
cases:16.93%
controls:5.79%
cases:20.85%
controls:16.60%
31
261
244
2481
22
150
253
2592
10
29
265
2713
—
22
26
251
2709
43
155
211
2520
44
390
167
1960
Monocytes [#/volume] in Blood
26484-6 [3001604]
2.6e-01
7.9e-01
9.0e-01
1.0e+50
1.6e+00
1.0e+00
4.5e-01
cases:11.27%
controls:8.90%
cases:10.18%
controls:4.89%
cases:2.91%
controls:1.20%
cases:1.82%
controls:0.00%
cases:4.40%
controls:0.91%
cases:13.78%
controls:5.50%
cases:19.91%
controls:13.70%
31
244
244
2498
28
134
247
2608
8
33
267
2709
5
0
270
2742
12
25
261
2710
35
147
219
2528
42
322
169
2028
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
2.8e-01
7.5e-01
9.0e-01
1.0e+50
1.6e+00
9.9e-01
4.9e-01
cases:12.00%
controls:9.37%
cases:10.55%
controls:5.29%
cases:2.91%
controls:1.20%
cases:1.82%
controls:0.00%
cases:4.76%
controls:0.95%
cases:14.17%
controls:5.76%
cases:21.33%
controls:14.21%
33
257
242
2485
29
145
246
2597
8
33
267
2709
5
0
270
2742
13
26
260
2709
36
154
218
2521
45
334
166
2016
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
1.8e-01
4.2e-01
8.2e-01
—
2.1e+00
1.3e+00
4.6e-01
cases:17.45%
controls:14.99%
cases:13.45%
controls:9.30%
cases:3.64%
controls:1.64%
—
—
cases:8.06%
controls:1.06%
cases:27.95%
controls:9.76%
cases:32.23%
controls:23.15%
48
411
227
2331
37
255
238
2487
10
45
265
2697
—
22
29
251
2706
71
261
183
2414
68
544
143
1806
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
-3.2e-03
7.1e-01
1.3e+00
—
2.3e+00
1.0e+00
2.1e-01
cases:7.64%
controls:7.66%
cases:7.64%
controls:3.90%
cases:1.82%
controls:0.51%
—
—
cases:4.76%
controls:0.48%
cases:10.63%
controls:4.15%
cases:14.69%
controls:12.21%
21
210
254
2532
21
107
254
2635
5
14
270
2728
—
13
13
260
2722
27
111
227
2564
31
287
180
2063
ketoprofen; oral, parenteral, rectal
M01AE03 [21603969]
3.3e-01
1.1e+00
—
—
2.1e+00
1.3e+00
3.9e-01
cases:6.55%
controls:4.81%
cases:3.27%
controls:1.17%
—
—
—
—
cases:2.56%
controls:0.33%
cases:4.72%
controls:1.38%
cases:5.69%
controls:3.91%
18
132
257
2610
9
32
266
2710
—
—
7
9
266
2726
12
37
242
2638
12
92
199
2258
Eosinophils [#/volume] in Blood
26449-9 [3013115]
2.8e-01
7.8e-01
9.9e-01
1.0e+50
1.5e+00
1.0e+00
4.8e-01
cases:12.00%
controls:9.34%
cases:10.55%
controls:5.11%
cases:3.27%
controls:1.24%
cases:1.82%
controls:0.00%
cases:4.40%
controls:0.99%
cases:14.17%
controls:5.64%
cases:21.33%
controls:14.34%
33
256
242
2486
29
140
246
2602
9
34
266
2708
5
0
270
2742
12
27
261
2708
36
151
218
2524
45
337
166
2013
Examination of ears and hearing
Z01.1 [45547279]
1.3e+00
—
—
—
—
1.9e+00
6.4e-01
cases:4.73%
controls:1.31%
—
—
—
—
—
—
—
—
cases:2.76%
controls:0.41%
cases:4.74%
controls:2.55%
13
36
262
2706
—
—
—
—
7
11
247
2664
10
60
201
2290
Bell palsy
G51.0 [45571815]
-1.0e+50
—
—
—
—
1.0e+50
3.2e+00
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
cases:3.94%
controls:0.00%
cases:6.16%
controls:0.26%
0
7
275
2735
—
—
—
—
10
0
244
2675
13
6
198
2344
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
—
1.6e+00
—
1.0e+50
—
3.2e+00
1.3e+00
—
—
cases:1.82%
controls:0.36%
—
—
cases:2.18%
controls:0.00%
—
—
cases:7.87%
controls:0.34%
cases:4.27%
controls:1.15%
—
5
10
270
2732
—
6
0
269
2742
—
20
9
234
2666
9
27
202
2323
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
2.9e-01
1.1e+00
—
—
—
2.1e+00
1.1e+00
cases:2.18%
controls:1.64%
cases:2.91%
controls:0.95%
—
—
—
—
—
—
cases:8.66%
controls:1.20%
cases:7.11%
controls:2.51%
6
45
269
2697
8
26
267
2716
—
—
—
22
32
232
2643
15
59
196
2291
fluconazole; oral, parenteral
J02AC01 [21603080]
7.1e-01
8.3e-01
-1.0e+50
—
—
2.2e+00
8.9e-01
cases:9.09%
controls:4.70%
cases:4.00%
controls:1.79%
cases:0.00%
controls:0.29%
—
—
—
—
cases:11.02%
controls:1.31%
cases:9.95%
controls:4.34%
25
129
250
2613
11
49
264
2693
0
8
275
2734
—
—
28
35
226
2640
21
102
190
2248
Dental examination
Z01.2 [45581002]
-2.9e-01
4.9e-01
—
—
2.1e+00
1.0e+00
2.2e-01
cases:5.45%
controls:7.15%
cases:4.00%
controls:2.48%
—
—
—
—
cases:2.56%
controls:0.33%
cases:6.69%
controls:2.47%
cases:12.32%
controls:10.13%
15
196
260
2546
11
68
264
2674
—
—
7
9
266
2726
17
66
237
2609
26
238
185
2112
codeine and paracetamol
N02AJ06 [1123647]
-1.8e-01
3.9e-01
—
—
1.8e+00
1.3e+00
2.6e-01
cases:11.27%
controls:13.20%
cases:7.27%
controls:5.03%
—
—
—
—
cases:4.40%
controls:0.77%
cases:17.32%
controls:5.23%
cases:17.54%
controls:14.13%
31
362
244
2380
20
138
255
2604
—
—
12
21
261
2714
44
140
210
2535
37
332
174
2018
Removal of sutures
SPAT1153 [2001700254]
5.1e-01
6.7e-01
—
—
—
2.0e+00
1.1e+00
cases:9.09%
controls:5.65%
cases:2.55%
controls:1.31%
—
—
—
—
—
—
cases:7.09%
controls:1.01%
cases:9.00%
controls:3.32%
25
155
250
2587
7
36
268
2706
—
—
—
18
27
236
2648
19
78
192
2272
enoxaparin; parenteral
B01AB05 [21600976]
5.7e-01
1.4e+00
—
—
—
1.6e+00
5.6e-01
cases:6.91%
controls:4.01%
cases:4.00%
controls:1.06%
—
—
—
—
—
—
cases:5.51%
controls:1.12%
cases:7.11%
controls:4.17%
19
110
256
2632
11
29
264
2713
—
—
—
14
30
240
2645
15
98
196
2252
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
1.7e-01
4.2e-01
—
—
2.9e+00
7.6e-01
2.7e-01
cases:7.27%
controls:6.20%
cases:5.09%
controls:3.39%
—
—
—
—
cases:4.03%
controls:0.22%
cases:7.09%
controls:3.44%
cases:14.69%
controls:11.62%
20
170
255
2572
14
93
261
2649
—
—
11
6
262
2729
18
92
236
2583
31
273
180
2077
benzathine phenoxymethylpenicillin; oral
J01CE10 [21602850]
2.2e-01
3.6e-01
—
—
1.8e+00
1.1e+00
2.7e-01
cases:13.09%
controls:10.80%
cases:4.36%
controls:3.10%
—
—
—
—
cases:2.93%
controls:0.48%
cases:7.87%
controls:2.80%
cases:14.22%
controls:11.19%
36
296
239
2446
12
85
263
2657
—
—
8
13
265
2722
20
75
234
2600
30
263
181
2087
phenoxymethylpenicillin; oral
J01CE02 [21602842]
2.2e-01
3.6e-01
—
—
1.8e+00
1.1e+00
2.7e-01
cases:13.09%
controls:10.80%
cases:4.36%
controls:3.10%
—
—
—
—
cases:2.93%
controls:0.48%
cases:7.87%
controls:2.80%
cases:14.22%
controls:11.19%
36
296
239
2446
12
85
263
2657
—
—
8
13
265
2722
20
75
234
2600
30
263
181
2087
Telephone prescription or other care instructions
WZB00 [2001310884]
2.3e-01
1.0e+00
—
—
—
1.7e+00
1.1e+00
cases:4.73%
controls:3.79%
cases:2.55%
controls:0.91%
—
—
—
—
—
—
cases:5.12%
controls:0.93%
cases:9.95%
controls:3.66%
13
104
262
2638
7
25
268
2717
—
—
—
13
25
241
2650
21
86
190
2264
Medical doctor
Z2221 [2001311556]
6.4e-01
1.1e+00
—
—
—
1.7e+00
1.1e+00
cases:7.27%
controls:3.98%
cases:4.36%
controls:1.53%
—
—
—
—
—
—
cases:4.72%
controls:0.93%
cases:7.58%
controls:2.55%
20
109
255
2633
12
42
263
2700
—
—
—
12
25
242
2650
16
60
195
2290
General Practice Dentistry
1223G0001X [38003675]
1.7e+00
1.0e+50
—
—
1.0e+50
—
2.8e+00
cases:1.82%
controls:0.33%
cases:2.18%
controls:0.00%
—
—
—
—
cases:1.83%
controls:0.00%
—
—
cases:5.21%
controls:0.34%
5
9
270
2733
6
0
269
2742
—
—
5
0
268
2735
—
11
8
200
2342
Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34548-8 [3045783]
-1.4e-01
1.4e-02
1.9e+00
—
2.7e+00
6.9e-01
2.2e-01
cases:3.64%
controls:4.16%
cases:2.18%
controls:2.15%
cases:2.18%
controls:0.33%
—
—
cases:4.76%
controls:0.33%
cases:3.94%
controls:2.02%
cases:3.79%
controls:3.06%
10
114
265
2628
6
59
269
2683
6
9
269
2733
—
13
9
260
2726
10
54
244
2621
8
72
203
2278
Counselling and guidance which enhance independent living
R2130 [2001310196]
—
2.0e+00
—
—
—
2.6e+00
1.2e+00
—
—
cases:1.82%
controls:0.26%
—
—
—
—
—
—
cases:3.94%
controls:0.30%
cases:3.32%
controls:0.98%
—
5
7
270
2735
—
—
—
10
8
244
2667
7
23
204
2327
ibuprofen
R02AX02 [1588667]
-1.2e-01
2.9e-01
1.1e+00
—
1.7e+00
9.1e-01
2.8e-01
cases:27.64%
controls:30.16%
cases:17.45%
controls:13.68%
cases:4.73%
controls:1.68%
—
—
cases:9.52%
controls:1.90%
cases:27.95%
controls:13.46%
cases:36.49%
controls:30.21%
76
827
199
1915
48
375
227
2367
13
46
262
2696
—
26
52
247
2683
71
360
183
2315
77
710
134
1640
ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]
-1.2e-01
2.9e-01
1.1e+00
—
1.7e+00
9.1e-01
2.8e-01
cases:27.64%
controls:30.16%
cases:17.45%
controls:13.68%
cases:4.73%
controls:1.68%
—
—
cases:9.52%
controls:1.90%
cases:27.95%
controls:13.46%
cases:36.49%
controls:30.21%
76
827
199
1915
48
375
227
2367
13
46
262
2696
—
26
52
247
2683
71
360
183
2315
77
710
134
1640
Extensive body CT
JN4BD [2001310899]
—
—
—
—
—
—
2.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:5.21%
controls:0.43%
—
—
—
—
—
—
11
10
200
2340
Localized swelling, mass and lump, unspecified
R22.9 [45577788]
—
2.5e+00
1.0e+50
—
—
—
9.4e-01
—
—
cases:4.36%
controls:0.36%
cases:2.91%
controls:0.00%
—
—
—
—
—
—
cases:3.32%
controls:1.32%
—
12
10
263
2732
8
0
267
2742
—
—
—
7
31
204
2319
Intravenous
ZX120 [2001311495]
1.0e+00
—
—
—
—
2.5e+00
1.3e+00
cases:1.82%
controls:0.66%
—
—
—
—
—
—
—
—
cases:3.15%
controls:0.26%
cases:2.84%
controls:0.77%
5
18
270
2724
—
—
—
—
8
7
246
2668
6
18
205
2332
Basophils/Leukocytes in Blood
30180-4 [3022096]
3.3e-01
7.2e-01
9.3e-01
—
1.5e+00
9.3e-01
5.8e-01
cases:10.91%
controls:8.06%
cases:8.73%
controls:4.45%
cases:2.91%
controls:1.17%
—
—
cases:3.66%
controls:0.80%
cases:11.81%
controls:5.01%
cases:19.43%
controls:11.87%
30
221
245
2521
24
122
251
2620
8
32
267
2710
—
10
22
263
2713
30
134
224
2541
41
279
170
2071
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
3.3e-01
7.2e-01
9.3e-01
—
1.5e+00
9.2e-01
5.7e-01
cases:10.91%
controls:8.10%
cases:8.73%
controls:4.45%
cases:2.91%
controls:1.17%
—
—
cases:3.66%
controls:0.80%
cases:11.81%
controls:5.08%
cases:19.43%
controls:11.96%
30
222
245
2520
24
122
251
2620
8
32
267
2710
—
10
22
263
2713
30
136
224
2539
41
281
170
2069
nystatin; vaginal
G01AA01 [21602363]
1.5e+00
—
—
—
—
—
2.5e+00
cases:2.55%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
cases:4.74%
controls:0.43%
7
16
268
2726
—
—
—
—
—
10
10
201
2340
nystatin
D01AA01 [21601911]
1.5e+00
—
—
—
—
—
2.5e+00
cases:2.55%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
cases:4.74%
controls:0.43%
7
16
268
2726
—
—
—
—
—
10
10
201
2340
metronidazole and furazolidone
P01AB51 [45893518]
1.5e+00
—
—
—
—
—
2.5e+00
cases:2.55%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
cases:4.74%
controls:0.43%
7
16
268
2726
—
—
—
—
—
10
10
201
2340
Cytology report of Tissue fine needle aspirate Cyto stain
33718-8 [3043109]
-1.0e+50
—
1.0e+50
1.0e+50
1.0e+50
—
2.4e+00
cases:0.00%
controls:0.18%
—
—
cases:6.55%
controls:0.00%
cases:1.82%
controls:0.00%
cases:2.56%
controls:0.00%
—
—
cases:4.27%
controls:0.38%
0
5
275
2737
—
18
0
257
2742
5
0
270
2742
7
0
266
2735
—
9
9
202
2341
Immunization
WW200 [2001310599]
-1.0e+50
-1.0e+50
—
—
—
—
2.4e+00
cases:0.00%
controls:0.29%
cases:0.00%
controls:0.18%
—
—
—
—
—
—
—
—
cases:2.37%
controls:0.21%
0
8
275
2734
0
5
275
2737
—
—
—
—
5
5
206
2345
Clinic/Center
261Q00000X [38004207]
-1.0e+50
—
—
—
—
—
2.4e+00
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
cases:2.37%
controls:0.21%
0
16
275
2726
—
—
—
—
—
5
5
206
2345
General anaesthesia
WX402 [2001310806]
1.1e+00
1.4e+00
—
1.0e+50
1.0e+50
2.4e+00
7.2e-01
cases:2.18%
controls:0.77%
cases:2.18%
controls:0.55%
—
—
cases:3.27%
controls:0.00%
cases:3.66%
controls:0.00%
cases:5.91%
controls:0.56%
cases:5.69%
controls:2.85%
6
21
269
2721
6
15
269
2727
—
9
0
266
2742
10
0
263
2735
15
15
239
2660
12
67
199
2283
Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 [3006217]
-1.0e+50
—
—
—
1.0e+50
2.4e+00
—
cases:0.00%
controls:0.58%
—
—
—
—
—
—
cases:1.83%
controls:0.00%
cases:2.76%
controls:0.26%
—
—
0
16
275
2726
—
—
—
5
0
268
2735
7
7
247
2668
—
More than three and less than five hours
ZXE20 [2001311408]
—
1.7e+00
—
—
—
2.4e+00
—
—
—
cases:2.18%
controls:0.40%
—
—
—
—
—
—
cases:2.36%
controls:0.22%
—
—
—
6
11
269
2731
—
—
—
6
6
248
2669
—
Extensive MRI examination of brain with high intensity magnet
AA1CG [2001300116]
—
-1.0e+50
—
—
—
2.4e+00
2.2e+00
—
—
cases:0.00%
controls:0.29%
—
—
—
—
—
—
cases:1.97%
controls:0.19%
cases:2.37%
controls:0.26%
—
0
8
275
2734
—
—
—
5
5
249
2670
5
6
206
2344
triamcinolone and antiinfectives
S02CA04 [21605176]
1.4e+00
—
—
—
—
—
2.4e+00
cases:2.91%
controls:0.77%
—
—
—
—
—
—
—
—
—
—
cases:4.74%
controls:0.47%
8
21
267
2721
—
—
—
—
—
10
11
201
2339
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
-1.7e-01
8.3e-02
8.0e-01
—
1.5e+00
1.8e-01
-2.3e-01
cases:22.91%
controls:26.04%
cases:22.91%
controls:21.48%
cases:9.45%
controls:4.49%
—
—
cases:16.85%
controls:4.20%
cases:25.98%
controls:22.65%
cases:34.60%
controls:39.87%
63
714
212
2028
63
589
212
2153
26
123
249
2619
—
46
115
227
2620
66
606
188
2069
73
937
138
1413
Treatment of reopened or infected surgical wound
SPAT1144 [2001700245]
—
2.3e+00
—
—
—
—
—
—
—
cases:2.18%
controls:0.22%
—
—
—
—
—
—
—
—
—
—
—
6
6
269
2736
—
—
—
—
—
Localized swelling, mass and lump, neck
R22.1 [45592412]
2.3e+00
—
1.0e+50
—
1.0e+50
1.0e+50
—
cases:2.18%
controls:0.22%
—
—
cases:9.09%
controls:0.00%
—
—
cases:5.49%
controls:0.00%
cases:3.54%
controls:0.00%
—
—
6
6
269
2736
—
25
0
250
2742
—
15
0
258
2735
9
0
245
2675
—
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
T81.0 [45599741]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.84%
controls:0.30%
—
—
—
—
—
—
6
7
205
2343
pH of Serum or Plasma
2753-2 [3018418]
-1.4e-01
1.0e+00
—
—
—
1.2e+00
3.3e-01
cases:4.00%
controls:4.56%
cases:6.18%
controls:2.30%
—
—
—
—
—
—
cases:7.87%
controls:2.39%
cases:9.48%
controls:7.02%
11
125
264
2617
17
63
258
2679
—
—
—
20
64
234
2611
20
165
191
2185
General Practice
1 [38004446]
9.3e-02
1.5e-01
1.6e+00
—
1.3e+00
7.3e-01
2.5e-01
cases:15.27%
controls:14.11%
cases:6.91%
controls:6.02%
cases:4.00%
controls:0.88%
—
—
cases:3.66%
controls:0.99%
cases:12.99%
controls:6.73%
cases:20.38%
controls:16.55%
42
387
233
2355
19
165
256
2577
11
24
264
2718
—
10
27
263
2708
33
180
221
2495
43
389
168
1961
Lump/swelling localized
S04 [2002000969]
1.0e+00
2.3e+00
—
—
—
—
—
cases:1.82%
controls:0.66%
cases:4.36%
controls:0.47%
—
—
—
—
—
—
—
—
—
—
5
18
270
2724
12
13
263
2729
—
—
—
—
—
Fractional oxyhemoglobin in Arterial blood
2714-4 [3014007]
-1.0e+50
—
—
—
1.0e+50
2.2e+00
—
cases:0.00%
controls:0.62%
—
—
—
—
—
—
cases:1.83%
controls:0.00%
cases:2.76%
controls:0.30%
—
—
0
17
275
2725
—
—
—
5
0
268
2735
7
8
247
2667
—
Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2030-5 [3028653]
-1.0e+50
—
—
—
1.0e+50
2.2e+00
—
cases:0.00%
controls:0.58%
—
—
—
—
—
—
cases:1.83%
controls:0.00%
cases:2.36%
controls:0.26%
—
—
0
16
275
2726
—
—
—
5
0
268
2735
6
7
248
2668
—
Stomatognathic treatment, basic
SHA02 [2001310406]
-1.0e+50
—
—
—
—
—
2.2e+00
cases:0.00%
controls:0.36%
—
—
—
—
—
—
—
—
—
—
cases:3.79%
controls:0.43%
0
10
275
2732
—
—
—
—
—
8
10
203
2340
Palliative care
Z51.5 [45547323]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.32%
controls:0.38%
—
—
—
—
—
—
7
9
204
2341
Removal of sutures from oral mucosa
SXB00 [2001310580]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.32%
controls:0.38%
—
—
—
—
—
—
7
9
204
2341
lactulose; oral
A06AD11 [21600571]
1.8e-02
6.7e-01
—
—
—
2.2e+00
-6.2e-02
cases:1.82%
controls:1.79%
cases:2.18%
controls:1.13%
—
—
—
—
—
—
cases:9.45%
controls:1.20%
cases:2.84%
controls:3.02%
5
49
270
2693
6
31
269
2711
—
—
—
24
32
230
2643
6
71
205
2279
Changing form of teeth in prepation for prosthodontic work
SPA00 [2001310458]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.84%
controls:0.34%
—
—
—
—
—
—
6
8
205
2342
Cathetrisation of artery
TPH07 [2001309747]
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
cases:2.76%
controls:0.34%
—
—
—
—
—
—
—
7
9
247
2666
—
Other healthcare associate professional
Z3229 [2001311561]
6.2e-01
—
—
—
—
2.1e+00
1.3e+00
cases:2.55%
controls:1.39%
—
—
—
—
—
—
—
—
cases:2.76%
controls:0.34%
cases:4.74%
controls:1.40%
7
38
268
2704
—
—
—
—
7
9
247
2666
10
33
201
2317
Ear microscopy
UDC00 [2001301558]
-1.0e+50
—
—
—
—
—
2.1e+00
cases:0.00%
controls:0.51%
—
—
—
—
—
—
—
—
—
—
cases:5.69%
controls:0.72%
0
14
275
2728
—
—
—
—
—
12
17
199
2333
Dental impressions
SBB10 [2001310299]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.32%
controls:0.43%
—
—
—
—
—
—
7
10
204
2340
Periodontitis pronounced
K05.31 [2000502729]
—
—
—
—
—
2.1e+00
5.4e-01
—
—
—
—
—
—
—
—
—
—
cases:4.33%
controls:0.56%
cases:3.32%
controls:1.96%
—
—
—
—
—
11
15
243
2660
7
46
204
2304
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
-7.3e-02
4.6e-01
7.6e-01
1.0e+50
2.0e+00
3.0e-01
1.3e-01
cases:14.91%
controls:15.86%
cases:13.09%
controls:8.68%
cases:2.55%
controls:1.20%
cases:2.91%
controls:0.00%
cases:6.59%
controls:0.91%
cases:11.81%
controls:9.01%
cases:23.70%
controls:21.40%
41
435
234
2307
36
238
239
2504
7
33
268
2709
8
0
267
2742
18
25
255
2710
30
241
224
2434
50
503
161
1847
Internal Medicine
11 [38004456]
3.7e-02
4.8e-01
9.1e-01
—
1.1e+00
8.9e-01
2.7e-01
cases:23.27%
controls:22.61%
cases:13.45%
controls:8.79%
cases:3.64%
controls:1.50%
—
—
cases:5.13%
controls:1.72%
cases:18.11%
controls:8.30%
cases:25.12%
controls:20.43%
64
620
211
2122
37
241
238
2501
10
41
265
2701
—
14
47
259
2688
46
222
208
2453
53
480
158
1870
Intravenous general anesthesia
WX404 [2001310807]
4.5e-01
—
—
—
—
2.0e+00
1.2e+00
cases:3.27%
controls:2.12%
—
—
—
—
—
—
—
—
cases:2.76%
controls:0.37%
cases:3.32%
controls:1.06%
9
58
266
2684
—
—
—
—
7
10
247
2665
7
25
204
2325
Body CT examination
JN4AD [2001310897]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:4.74%
controls:0.68%
—
—
—
—
—
—
10
16
201
2334
Actinic keratosis
L57.0 [45591640]
—
1.3e+00
—
—
—
2.0e+00
8.8e-01
—
—
cases:1.82%
controls:0.51%
—
—
—
—
—
—
cases:3.15%
controls:0.45%
cases:3.32%
controls:1.40%
—
5
14
270
2728
—
—
—
8
12
246
2663
7
33
204
2317
Oxygen saturation in Arterial blood
2708-6 [3016502]
—
—
—
—
—
2.0e+00
7.7e-02
—
—
—
—
—
—
—
—
—
—
cases:3.15%
controls:0.45%
cases:2.84%
controls:2.64%
—
—
—
—
—
8
12
246
2663
6
62
205
2288
Bacteria identified in Skin by Aerobe culture
620-5 [3007853]
4.4e-01
—
—
—
—
2.0e+00
7.8e-01
cases:2.18%
controls:1.42%
—
—
—
—
—
—
—
—
cases:4.33%
controls:0.64%
cases:5.21%
controls:2.47%
6
39
269
2703
—
—
—
—
11
17
243
2658
11
58
200
2292
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
2.2e-01
8.6e-01
—
—
—
1.9e+00
8.4e-01
cases:4.00%
controls:3.25%
cases:3.64%
controls:1.57%
—
—
—
—
—
—
cases:8.27%
controls:1.27%
cases:9.48%
controls:4.34%
11
89
264
2653
10
43
265
2699
—
—
—
21
34
233
2641
20
102
191
2248
Preparing and fitting the occlusal splint in the mouth
SHB00 [2001310410]
-1.0e+50
—
—
—
—
2.2e+00
1.9e+00
cases:0.00%
controls:0.51%
—
—
—
—
—
—
—
—
cases:1.97%
controls:0.22%
cases:3.32%
controls:0.51%
0
14
275
2728
—
—
—
—
5
6
249
2669
7
12
204
2338
Biopsy of skin and subcutaneous tissue
TQX10 [2001310152]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.79%
controls:0.60%
—
—
—
—
—
—
8
14
203
2336
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]
5.7e-01
—
—
—
—
1.9e+00
9.1e-01
cases:2.55%
controls:1.46%
—
—
—
—
—
—
—
—
cases:3.54%
controls:0.56%
cases:4.74%
controls:1.96%
7
40
268
2702
—
—
—
—
9
15
245
2660
10
46
201
2304
Assessment of need for oral health care, standard
SAD01 [2001310287]
—
—
—
—
—
1.8e+00
9.6e-01
—
—
—
—
—
—
—
—
—
—
cases:2.76%
controls:0.45%
cases:4.74%
controls:1.87%
—
—
—
—
—
7
12
247
2663
10
44
201
2306
EKG study
11524-6 [3013512]
7.9e-02
1.5e-02
1.8e+00
—
1.4e+00
6.5e-01
4.1e-02
cases:6.91%
controls:6.42%
cases:4.36%
controls:4.30%
cases:4.36%
controls:0.73%
—
—
cases:2.56%
controls:0.66%
cases:7.48%
controls:4.04%
cases:10.90%
controls:10.51%
19
176
256
2566
12
118
263
2624
12
20
263
2722
—
7
18
266
2717
19
108
235
2567
23
247
188
2103
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
1.6e-01
8.3e-01
1.8e+00
—
—
1.8e+00
6.0e-01
cases:5.45%
controls:4.67%
cases:4.73%
controls:2.12%
cases:1.82%
controls:0.29%
—
—
—
—
cases:12.60%
controls:2.32%
cases:11.37%
controls:6.60%
15
128
260
2614
13
58
262
2684
5
8
270
2734
—
—
32
62
222
2613
24
155
187
2195
Audiology
64 [38004489]
4.5e-01
2.8e-01
—
—
—
1.8e+00
8.0e-01
cases:4.73%
controls:3.06%
cases:1.82%
controls:1.39%
—
—
—
—
—
—
cases:8.27%
controls:1.50%
cases:7.11%
controls:3.32%
13
84
262
2658
5
38
270
2704
—
—
—
21
40
233
2635
15
78
196
2272
dexamethasone and antiinfectives
S02CA06 [21605178]
1.1e+00
—
—
—
—
—
1.8e+00
cases:2.91%
controls:0.95%
—
—
—
—
—
—
—
—
—
—
cases:6.64%
controls:1.19%
8
26
267
2716
—
—
—
—
—
14
28
197
2322
Short blood count panel - Blood
55429-5 [40758558]
-2.2e-02
5.4e-01
—
—
—
1.8e+00
3.1e-01
cases:4.00%
controls:4.08%
cases:2.91%
controls:1.71%
—
—
—
—
—
—
cases:9.06%
controls:1.68%
cases:8.53%
controls:6.38%
11
112
264
2630
8
47
267
2695
—
—
—
23
45
231
2630
18
150
193
2200
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
3.2e-02
2.7e-01
2.3e-01
—
1.2e+00
5.3e-01
5.4e-02
cases:30.55%
controls:29.87%
cases:28.36%
controls:23.16%
cases:5.45%
controls:4.38%
—
—
cases:11.72%
controls:3.73%
cases:35.43%
controls:24.49%
cases:47.87%
controls:46.51%
84
819
191
1923
78
635
197
2107
15
120
260
2622
—
32
102
241
2633
90
655
164
2020
101
1093
110
1257
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
cases:2.76%
controls:0.49%
—
—
—
—
—
—
—
7
13
247
2662
—
Base excess in Arterial blood by calculation
1925-7 [3003396]
4.5e-01
—
—
—
—
1.8e+00
2.9e-01
cases:1.82%
controls:1.17%
—
—
—
—
—
—
—
—
cases:3.15%
controls:0.56%
cases:3.79%
controls:2.85%
5
32
270
2710
—
—
—
—
8
15
246
2660
8
67
203
2283
General medical examination
Z00.0 [45585791]
6.1e-01
1.7e+00
—
—
—
1.5e+00
6.4e-01
cases:4.00%
controls:2.22%
cases:3.27%
controls:0.62%
—
—
—
—
—
—
cases:3.15%
controls:0.75%
cases:4.27%
controls:2.30%
11
61
264
2681
9
17
266
2725
—
—
—
8
20
246
2655
9
54
202
2296
Acute bronchitis
J20 [45581849]
1.7e+00
—
—
—
—
—
—
cases:3.27%
controls:0.62%
—
—
—
—
—
—
—
—
—
—
—
—
9
17
266
2725
—
—
—
—
—
—
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
4.5e-01
—
—
—
—
1.7e+00
3.7e-01
cases:1.82%
controls:1.17%
—
—
—
—
—
—
—
—
cases:3.15%
controls:0.60%
cases:3.79%
controls:2.64%
5
32
270
2710
—
—
—
—
8
16
246
2659
8
62
203
2288
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
4.5e-01
—
—
—
—
1.7e+00
3.7e-01
cases:1.82%
controls:1.17%
—
—
—
—
—
—
—
—
cases:3.15%
controls:0.60%
cases:3.79%
controls:2.64%
5
32
270
2710
—
—
—
—
8
16
246
2659
8
62
203
2288
Right side
ZXA00 [2001311346]
5.6e-01
8.3e-01
—
1.0e+50
1.0e+50
1.7e+00
4.3e-01
cases:6.91%
controls:4.05%
cases:2.55%
controls:1.13%
—
—
cases:1.82%
controls:0.00%
cases:2.20%
controls:0.00%
cases:5.12%
controls:1.01%
cases:4.27%
controls:2.81%
19
111
256
2631
7
31
268
2711
—
5
0
270
2742
6
0
267
2735
13
27
241
2648
9
66
202
2284
Physical Medicine And Rehabilitation
25 [38004468]
1.2e-01
7.0e-01
—
—
—
1.7e+00
2.7e-01
cases:7.27%
controls:6.53%
cases:4.36%
controls:2.22%
—
—
—
—
—
—
cases:8.27%
controls:1.68%
cases:9.00%
controls:7.02%
20
179
255
2563
12
61
263
2681
—
—
—
21
45
233
2630
19
165
192
2185
Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 [3020059]
1.7e-01
8.3e-01
—
—
—
1.6e+00
6.4e-01
cases:2.55%
controls:2.15%
cases:2.55%
controls:1.13%
—
—
—
—
—
—
cases:5.51%
controls:1.12%
cases:8.06%
controls:4.43%
7
59
268
2683
7
31
268
2711
—
—
—
14
30
240
2645
17
104
194
2246
General Surgery
2 [38004447]
1.4e-01
6.2e-01
1.6e+00
—
1.2e+00
5.0e-01
5.2e-01
cases:20.00%
controls:17.91%
cases:9.82%
controls:5.51%
cases:3.64%
controls:0.73%
—
—
cases:2.56%
controls:0.80%
cases:7.48%
controls:4.67%
cases:21.80%
controls:14.21%
55
491
220
2251
27
151
248
2591
10
20
265
2722
—
7
22
266
2713
19
125
235
2550
46
334
165
2016
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
2.1e-01
3.0e-01
1.6e+00
—
1.3e+00
2.5e-01
4.8e-02
cases:13.45%
controls:11.23%
cases:7.64%
controls:5.76%
cases:3.64%
controls:0.73%
—
—
cases:2.93%
controls:0.84%
cases:8.27%
controls:6.58%
cases:19.91%
controls:19.15%
37
308
238
2434
21
158
254
2584
10
20
265
2722
—
8
23
265
2712
21
176
233
2499
42
450
169
1900
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
2.5e-01
8.7e-01
—
—
1.6e+00
5.0e-01
5.0e-01
cases:9.82%
controls:7.84%
cases:5.45%
controls:2.37%
—
—
—
—
cases:2.93%
controls:0.59%
cases:3.94%
controls:2.43%
cases:9.48%
controls:5.96%
27
215
248
2527
15
65
260
2677
—
—
8
16
265
2719
10
65
244
2610
20
140
191
2210
Skin symptom/complaint other
S29 [2002000993]
6.2e-01
1.1e+00
—
—
—
1.6e+00
4.8e-01
cases:3.27%
controls:1.79%
cases:1.82%
controls:0.62%
—
—
—
—
—
—
cases:3.94%
controls:0.82%
cases:4.27%
controls:2.68%
9
49
266
2693
5
17
270
2725
—
—
—
10
22
244
2653
9
63
202
2287
tinzaparin; parenteral
B01AB10 [21600981]
—
—
—
—
—
—
1.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:4.74%
controls:1.02%
—
—
—
—
—
—
10
24
201
2326
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
1.8e-01
1.7e+00
—
—
—
—
1.6e+00
cases:2.18%
controls:1.82%
cases:1.82%
controls:0.33%
—
—
—
—
—
—
—
—
cases:8.53%
controls:1.91%
6
50
269
2692
5
9
270
2733
—
—
—
—
18
45
193
2305
clindamycin; oral, parenteral
J01FF01 [21602985]
3.6e-01
7.8e-01
—
—
—
1.2e+00
1.5e+00
cases:4.73%
controls:3.36%
cases:1.82%
controls:0.84%
—
—
—
—
—
—
cases:2.36%
controls:0.71%
cases:9.48%
controls:2.30%
13
92
262
2650
5
23
270
2719
—
—
—
6
19
248
2656
20
54
191
2296
antibiotics in combination with corticosteroids
D01AA20 [21601918]
8.4e-01
—
—
—
—
—
1.5e+00
cases:4.36%
controls:1.93%
—
—
—
—
—
—
—
—
—
—
cases:5.69%
controls:1.36%
12
53
263
2689
—
—
—
—
—
12
32
199
2318
Periodontal treatment
SDA03 [2001310328]
-2.9e-02
-1.2e-01
—
—
1.4e+00
1.5e+00
1.1e-01
cases:5.82%
controls:5.98%
cases:2.18%
controls:2.44%
—
—
—
—
cases:1.83%
controls:0.48%
cases:10.63%
controls:2.65%
cases:10.90%
controls:9.91%
16
164
259
2578
6
67
269
2675
—
—
5
13
268
2722
27
71
227
2604
23
233
188
2117
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
—
—
—
—
—
—
1.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:4.27%
controls:1.02%
—
—
—
—
—
—
9
24
202
2326
Fitting and adjustment of hearing aid
Z46.1 [45595518]
1.4e+00
—
—
—
—
—
—
cases:4.00%
controls:0.98%
—
—
—
—
—
—
—
—
—
—
—
—
11
27
264
2715
—
—
—
—
—
—
One-surface restoration
SFA10 [2001310358]
-5.0e-02
6.4e-01
—
—
1.3e+00
8.2e-01
6.0e-01
cases:12.36%
controls:12.91%
cases:8.73%
controls:4.78%
—
—
—
—
cases:2.56%
controls:0.73%
cases:11.02%
controls:5.16%
cases:24.17%
controls:14.85%
34
354
241
2388
24
131
251
2611
—
—
7
20
266
2715
28
138
226
2537
51
349
160
2001
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 [3051714]
-5.1e-01
4.4e-01
—
—
—
1.4e+00
6.2e-02
cases:1.82%
controls:2.99%
cases:2.18%
controls:1.42%
—
—
—
—
—
—
cases:3.94%
controls:1.01%
cases:4.74%
controls:4.47%
5
82
270
2660
6
39
269
2703
—
—
—
10
27
244
2648
10
105
201
2245
Urate [Moles/volume] in Serum or Plasma
14933-6 [3026493]
-2.1e-01
—
—
—
—
1.4e+00
3.3e-01
cases:4.00%
controls:4.89%
—
—
—
—
—
—
—
—
cases:6.30%
controls:1.68%
cases:9.00%
controls:6.64%
11
134
264
2608
—
—
—
—
16
45
238
2630
19
156
192
2194
Simple examination of mouth
SAA01 [2001310274]
7.6e-02
5.1e-01
7.3e-01
—
4.9e-01
7.6e-01
6.0e-01
cases:20.00%
controls:18.82%
cases:14.18%
controls:9.04%
cases:2.55%
controls:1.24%
—
—
cases:1.83%
controls:1.13%
cases:18.11%
controls:9.38%
cases:36.02%
controls:23.62%
55
516
220
2226
39
248
236
2494
7
34
268
2708
—
5
31
268
2704
46
251
208
2424
76
555
135
1795
Osmolality of Urine
2695-5 [3026782]
2.9e-01
3.6e-01
—
—
—
1.4e+00
5.1e-01
cases:4.00%
controls:3.03%
cases:1.82%
controls:1.28%
—
—
—
—
—
—
cases:4.33%
controls:1.16%
cases:6.16%
controls:3.79%
11
83
264
2659
5
35
270
2707
—
—
—
11
31
243
2644
13
89
198
2261
gabapentin; oral
N02BF01 [955005]
-1.8e-01
—
—
—
—
1.4e+00
2.7e-01
cases:2.18%
controls:2.59%
—
—
—
—
—
—
—
—
cases:4.33%
controls:1.16%
cases:4.74%
controls:3.66%
6
71
269
2671
—
—
—
—
11
31
243
2644
10
86
201
2264
Fever, unspecified
R50.9 [45582716]
—
—
—
—
—
1.5e+00
1.3e+00
—
—
—
—
—
—
—
—
—
—
cases:2.36%
controls:0.56%
cases:5.21%
controls:1.45%
—
—
—
—
—
6
15
248
2660
11
34
200
2316
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
1.3e-01
2.5e-01
—
—
—
1.3e+00
3.2e-01
cases:3.27%
controls:2.88%
cases:1.82%
controls:1.42%
—
—
—
—
—
—
cases:4.72%
controls:1.31%
cases:7.11%
controls:5.28%
9
79
266
2663
5
39
270
2703
—
—
—
12
35
242
2640
15
124
196
2226
combinations of corticosteroids
D07AB30 [21602118]
3.7e-01
7.5e-01
—
—
—
1.3e+00
5.8e-01
cases:15.27%
controls:11.05%
cases:6.91%
controls:3.39%
—
—
—
—
—
—
cases:12.20%
controls:3.66%
cases:18.96%
controls:11.57%
42
303
233
2439
19
93
256
2649
—
—
—
31
98
223
2577
40
272
171
2078
combinations of corticosteroids
D07XB30 [21602188]
3.7e-01
7.5e-01
—
—
—
1.3e+00
5.8e-01
cases:15.27%
controls:11.05%
cases:6.91%
controls:3.39%
—
—
—
—
—
—
cases:12.20%
controls:3.66%
cases:18.96%
controls:11.57%
42
303
233
2439
19
93
256
2649
—
—
—
31
98
223
2577
40
272
171
2078
Small restoration
SFA00 [2001310357]
1.7e-01
—
—
—
—
—
1.3e+00
cases:1.82%
controls:1.53%
—
—
—
—
—
—
—
—
—
—
cases:6.16%
controls:1.83%
5
42
270
2700
—
—
—
—
—
13
43
198
2307
Metamyelocytes/Leukocytes in Blood
28541-1 [3002179]
—
—
—
—
—
1.4e+00
1.2e+00
—
—
—
—
—
—
—
—
—
—
cases:1.97%
controls:0.49%
cases:5.69%
controls:1.70%
—
—
—
—
—
5
13
249
2662
12
40
199
2310
Pharmacy visit
OMOP4822462 [581458]
7.1e-02
2.3e-01
4.8e-01
5.4e-01
7.2e-01
5.2e-01
3.0e-01
cases:90.18%
controls:89.53%
cases:86.55%
controls:83.70%
cases:59.27%
controls:47.30%
cases:4.73%
controls:2.81%
cases:65.57%
controls:48.01%
cases:89.76%
controls:83.96%
cases:95.73%
controls:94.34%
248
2455
27
287
238
2295
37
447
163
1297
112
1445
13
77
262
2665
179
1313
94
1422
228
2246
26
429
202
2217
9
133
Urology
34 [38004474]
6.4e-01
-3.0e-03
—
—
—
1.2e+00
3.2e-01
cases:8.73%
controls:4.81%
cases:2.18%
controls:2.19%
—
—
—
—
—
—
cases:5.91%
controls:1.94%
cases:8.06%
controls:6.00%
24
132
251
2610
6
60
269
2682
—
—
—
15
52
239
2623
17
141
194
2209
Bacteria identified in Blood by Culture
600-7 [3023368]
1.4e-01
4.5e-01
—
—
1.6e+00
1.2e+00
6.9e-01
cases:3.64%
controls:3.17%
cases:2.55%
controls:1.64%
—
—
—
—
cases:2.20%
controls:0.44%
cases:7.09%
controls:2.36%
cases:11.85%
controls:6.34%
10
87
265
2655
7
45
268
2697
—
—
6
12
267
2723
18
63
236
2612
25
149
186
2201
Psychiatry
26 [38004469]
3.3e-01
9.4e-01
1.2e+00
—
1.3e+00
1.1e+00
7.2e-01
cases:5.09%
controls:3.72%
cases:5.09%
controls:2.04%
cases:2.55%
controls:0.80%
—
—
cases:2.93%
controls:0.80%
cases:5.51%
controls:1.87%
cases:7.11%
controls:3.57%
14
102
261
2640
14
56
261
2686
7
22
268
2720
—
8
22
265
2713
14
50
240
2625
15
84
196
2266
hydrocortisone aceponate
D07AC16 [21602135]
5.4e-01
6.2e-01
—
—
—
1.1e+00
4.9e-01
cases:11.64%
controls:7.11%
cases:4.73%
controls:2.59%
—
—
—
—
—
—
cases:5.91%
controls:2.09%
cases:11.37%
controls:7.32%
32
195
243
2547
13
71
262
2671
—
—
—
15
56
239
2619
24
172
187
2178
hydrocortisone
C05AA01 [21601608]
5.4e-01
6.1e-01
—
—
—
1.1e+00
4.8e-01
cases:11.64%
controls:7.15%
cases:4.73%
controls:2.63%
—
—
—
—
—
—
cases:5.91%
controls:2.09%
cases:11.37%
controls:7.36%
32
196
243
2546
13
72
262
2670
—
—
—
15
56
239
2619
24
173
187
2177
hydrocortisone
D07AA02 [21602102]
5.4e-01
6.2e-01
—
—
—
1.1e+00
4.9e-01
cases:11.64%
controls:7.11%
cases:4.73%
controls:2.59%
—
—
—
—
—
—
cases:5.91%
controls:2.09%
cases:11.37%
controls:7.32%
32
195
243
2547
13
71
262
2671
—
—
—
15
56
239
2619
24
172
187
2178
hydrocortisone buteprate
D07AB11 [21602115]
5.4e-01
6.2e-01
—
—
—
1.1e+00
4.9e-01
cases:11.64%
controls:7.11%
cases:4.73%
controls:2.59%
—
—
—
—
—
—
cases:5.91%
controls:2.09%
cases:11.37%
controls:7.32%
32
195
243
2547
13
71
262
2671
—
—
—
15
56
239
2619
24
172
187
2178
hydrocortisone butyrate
D07AB02 [21602106]
5.4e-01
6.2e-01
—
—
—
1.1e+00
4.9e-01
cases:11.64%
controls:7.11%
cases:4.73%
controls:2.59%
—
—
—
—
—
—
cases:5.91%
controls:2.09%
cases:11.37%
controls:7.32%
32
195
243
2547
13
71
262
2671
—
—
—
15
56
239
2619
24
172
187
2178
hydrocortisone
A07EA02 [21600654]
5.4e-01
6.1e-01
—
—
—
1.1e+00
4.8e-01
cases:11.64%
controls:7.15%
cases:4.73%
controls:2.63%
—
—
—
—
—
—
cases:5.91%
controls:2.09%
cases:11.37%
controls:7.36%
32
196
243
2546
13
72
262
2670
—
—
—
15
56
239
2619
24
173
187
2177
chloramphenicol
S01AA01 [21603554]
2.1e-01
2.6e-01
—
—
—
1.0e+00
3.5e-01
cases:8.00%
controls:6.60%
cases:3.27%
controls:2.55%
—
—
—
—
—
—
cases:5.91%
controls:2.24%
cases:12.32%
controls:9.02%
22
181
253
2561
9
70
266
2672
—
—
—
15
60
239
2615
26
212
185
2138
chloramphenicol
S03AA08 [21605197]
2.1e-01
2.6e-01
—
—
—
1.0e+00
3.5e-01
cases:8.00%
controls:6.60%
cases:3.27%
controls:2.55%
—
—
—
—
—
—
cases:5.91%
controls:2.24%
cases:12.32%
controls:9.02%
22
181
253
2561
9
70
266
2672
—
—
—
15
60
239
2615
26
212
185
2138
Emergency Room and Inpatient Visit
ERIP [262]
1.6e-01
-5.3e-02
—
—
—
9.5e-01
2.7e-01
cases:4.00%
controls:3.43%
cases:2.18%
controls:2.30%
—
—
—
—
—
—
cases:6.69%
controls:2.69%
cases:12.32%
controls:9.66%
11
94
264
2648
6
63
269
2679
—
—
—
17
72
237
2603
26
227
185
2123
Differential panel, method unspecified - Blood
69738-3 [42870588]
4.0e-03
3.3e-01
1.2e+00
—
1.6e+00
9.3e-01
4.2e-01
cases:5.45%
controls:5.43%
cases:4.73%
controls:3.43%
cases:2.91%
controls:0.88%
—
—
cases:2.20%
controls:0.44%
cases:8.27%
controls:3.44%
cases:11.37%
controls:7.79%
15
149
260
2593
13
94
262
2648
8
24
267
2718
—
6
12
267
2723
21
92
233
2583
24
183
187
2167
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
2.3e-01
6.1e-01
7.9e-01
—
1.4e+00
8.6e-01
4.6e-01
cases:10.55%
controls:8.57%
cases:8.73%
controls:4.92%
cases:2.55%
controls:1.17%
—
—
cases:3.30%
controls:0.84%
cases:11.81%
controls:5.35%
cases:18.48%
controls:12.51%
29
235
246
2507
24
135
251
2607
7
32
268
2710
—
9
23
264
2712
30
143
224
2532
39
294
172
2056
Monocytes/Leukocytes in Blood
26485-3 [3019069]
2.8e-01
7.0e-01
9.3e-01
—
1.4e+00
8.6e-01
5.4e-01
cases:10.55%
controls:8.17%
cases:8.73%
controls:4.52%
cases:2.91%
controls:1.17%
—
—
cases:3.30%
controls:0.80%
cases:11.42%
controls:5.20%
cases:18.96%
controls:11.96%
29
224
246
2518
24
124
251
2618
8
32
267
2710
—
9
22
264
2713
29
139
225
2536
40
281
171
2069
esomeprazole; oral, parenteral
A02BC05 [21600100]
1.3e-01
1.9e-01
—
—
—
8.3e-01
5.1e-01
cases:9.09%
controls:8.06%
cases:5.09%
controls:4.23%
—
—
—
—
—
—
cases:9.06%
controls:4.15%
cases:12.80%
controls:8.09%
25
221
250
2521
14
116
261
2626
—
—
—
23
111
231
2564
27
190
184
2160
Basic examination of mouth
SAA02 [2001310275]
2.2e-02
3.5e-01
1.2e+00
—
1.4e+00
8.2e-01
5.1e-01
cases:15.64%
controls:15.35%
cases:7.27%
controls:5.22%
cases:2.18%
controls:0.69%
—
—
cases:2.20%
controls:0.55%
cases:12.20%
controls:5.76%
cases:29.86%
controls:20.38%
43
421
232
2321
20
143
255
2599
6
19
269
2723
—
6
15
267
2720
31
154
223
2521
63
479
148
1871
Ophthalmology
18 [38004463]
5.7e-02
2.9e-01
7.9e-01
—
5.2e-01
8.1e-01
3.3e-01
cases:17.82%
controls:16.99%
cases:10.18%
controls:7.80%
cases:2.55%
controls:1.17%
—
—
cases:2.56%
controls:1.54%
cases:15.35%
controls:7.48%
cases:23.70%
controls:18.21%
49
466
226
2276
28
214
247
2528
7
32
268
2710
—
7
42
266
2693
39
200
215
2475
50
428
161
1922
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
2.1e-01
4.9e-01
8.6e-01
—
1.4e+00
8.1e-01
5.4e-01
cases:10.18%
controls:8.42%
cases:7.64%
controls:4.81%
cases:2.55%
controls:1.09%
—
—
cases:3.30%
controls:0.80%
cases:11.02%
controls:5.23%
cases:19.43%
controls:12.30%
28
231
247
2511
21
132
254
2610
7
30
268
2712
—
9
22
264
2713
28
140
226
2535
41
289
170
2061
pantoprazole; oral, parenteral
A02BC02 [21600097]
1.1e-01
4.0e-01
7.7e-01
—
6.4e-01
6.6e-01
4.9e-01
cases:17.45%
controls:15.94%
cases:13.45%
controls:9.41%
cases:4.36%
controls:2.08%
—
—
cases:4.03%
controls:2.16%
cases:17.72%
controls:9.98%
cases:28.44%
controls:19.53%
48
437
227
2305
37
258
238
2484
12
57
263
2685
—
11
59
262
2676
45
267
209
2408
60
459
151
1891
Uroflowmetry
44856007 [4261340]
7.5e-01
—
—
—
—
1.3e+00
5.2e-01
cases:4.00%
controls:1.93%
—
—
—
—
—
—
—
—
cases:2.36%
controls:0.64%
cases:3.32%
controls:2.00%
11
53
264
2689
—
—
—
—
6
17
248
2658
7
47
204
2303
Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
I63.5 [45605808]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.26%
0
5
275
2737
—
—
—
—
—
0
6
211
2344
Acute tubulo-interstitial nephritis
N10 [45543856]
2.5e-01
—
—
—
—
—
-5.9e-02
cases:1.82%
controls:1.42%
—
—
—
—
—
—
—
—
—
—
cases:2.37%
controls:2.51%
5
39
270
2703
—
—
—
—
—
5
59
206
2291
Hyperglycaemia, unspecified
R73.9 [45602038]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.30%
0
5
275
2737
—
—
—
—
—
0
7
211
2343
Calcium.ionized [Moles/volume] in Venous blood
41645-3 [3033705]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
0
7
254
2668
—
sulfadiazine and trimethoprim
J01EE02 [21602962]
4.8e-01
—
—
—
—
1.1e+00
6.1e-01
cases:4.00%
controls:2.52%
—
—
—
—
—
—
—
—
cases:2.76%
controls:0.93%
cases:4.74%
controls:2.64%
11
69
264
2673
—
—
—
—
7
25
247
2650
10
62
201
2288
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
F00.10*G30.1 [2000501573]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.22%
—
—
—
—
—
—
—
—
—
—
—
0
6
275
2736
—
—
—
—
—
Chronic atrial fibrillation
I48.2 [45591467]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
0
16
211
2334
fusidic acid
D09AA02 [21602265]
-1.4e-01
1.1e+00
—
—
—
1.4e+00
3.7e-01
cases:2.55%
controls:2.92%
cases:3.27%
controls:1.13%
—
—
—
—
—
—
cases:3.94%
controls:1.05%
cases:4.74%
controls:3.32%
7
80
268
2662
9
31
266
2711
—
—
—
10
28
244
2647
10
78
201
2272
aciclovir; oral, parenteral
J05AB01 [21603131]
-2.5e-01
—
—
—
—
—
9.4e-01
cases:1.82%
controls:2.33%
—
—
—
—
—
—
—
—
—
—
cases:4.27%
controls:1.70%
5
64
270
2678
—
—
—
—
—
9
40
202
2310
Complement+Immunoglobulin [Units/volume] in Red Blood Cells
4533-6 [3024403]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.36%
—
—
—
—
—
—
—
—
—
—
—
—
0
10
275
2732
—
—
—
—
—
—
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
—
—
—
—
—
—
9.0e-02
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.37%
controls:2.17%
—
—
—
—
—
—
5
51
206
2299
Foot and toes X-ray examination
NH3AA [2001308267]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.22%
—
—
—
—
—
—
—
—
—
—
—
0
6
275
2736
—
—
—
—
—
Microscopic observation [Identifier] in Buccal smear by Cyto stain
18501-7 [3018559]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.21%
—
—
—
—
—
—
0
5
211
2345
Choriogonadotropin [Units/volume] in Urine
25372-4 [3023511]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
275
2737
—
—
—
—
—
—
cloZAPine [Moles/volume] in Serum or Plasma
14656-3 [3000081]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.30%
—
—
—
—
—
—
0
7
211
2343
Myocardial infarction (acute) UNS no detected stenosis of the coronary artery
I21.90 [2000502438]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.22%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.26%
0
6
275
2736
—
—
—
—
—
0
6
211
2344
SMOKING - SMOKE2: yes - SMOKE3: current - SMOKE5: occasional
SMOKING-1-1-2 [2002330117]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.33%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
275
2733
—
—
—
—
—
—
acetazolamide; oral, parenteral
S01EC01 [21603693]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.40%
—
—
—
—
—
—
—
—
—
—
—
—
0
11
275
2731
—
—
—
—
—
—
Pregnancy confirmed
Z32.1 [45566418]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.38%
0
7
275
2735
—
—
—
—
—
0
9
211
2341
Intravenous administration of medicine
SPAT1255 [2001700356]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.62%
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
0
17
275
2725
0
7
275
2735
—
—
—
—
—
Other hammer toe(s) (acquired)
M20.4 [45562664]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.62%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.60%
0
17
275
2725
—
—
—
—
—
0
14
211
2336
epinephrine; parenteral
C01CA24 [21600303]
1.3e+00
—
—
—
—
—
—
cases:1.82%
controls:0.51%
—
—
—
—
—
—
—
—
—
—
—
—
5
14
270
2728
—
—
—
—
—
—
Mitral (valve) prolapse
I34.1 [45552788]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
cases:0.00%
controls:0.44%
cases:0.00%
controls:0.22%
—
—
—
—
—
—
cases:0.00%
controls:0.26%
cases:0.00%
controls:0.38%
0
12
275
2730
0
6
275
2736
—
—
—
0
7
254
2668
0
9
211
2341
Follow-up examination after surgery for other conditions
Z09.0 [45576131]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.36%
—
—
—
—
—
—
—
—
—
—
—
—
0
10
275
2732
—
—
—
—
—
—
Neutrophils [#/volume] in Blood
26499-4 [3017732]
3.9e-01
—
—
—
—
1.3e+00
1.1e-01
cases:1.82%
controls:1.24%
—
—
—
—
—
—
—
—
cases:2.76%
controls:0.75%
cases:3.32%
controls:2.98%
5
34
270
2708
—
—
—
—
7
20
247
2655
7
70
204
2280
Chronic glaucoma with open ventricular angle
H40.13 [2000502335]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.62%
—
—
—
—
—
—
—
—
—
—
—
0
17
275
2725
—
—
—
—
—
metoprolol; oral, parenteral
C07AB02 [21601684]
1.3e-01
1.3e-01
—
-1.0e+50
3.2e-01
2.5e-01
2.9e-01
cases:7.27%
controls:6.42%
cases:5.82%
controls:5.14%
—
—
cases:0.00%
controls:0.22%
cases:2.20%
controls:1.61%
cases:6.30%
controls:4.97%
cases:8.06%
controls:6.13%
20
176
255
2566
16
141
259
2601
—
0
6
275
2736
6
44
267
2691
16
133
238
2542
17
144
194
2206
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M
77147-7 [46236952]
—
—
—
—
—
1.7e+00
4.3e-01
—
—
—
—
—
—
—
—
—
—
cases:2.76%
controls:0.52%
cases:3.79%
controls:2.51%
—
—
—
—
—
7
14
247
2661
8
59
203
2291
Eye infection/inflammation other
F73 [2002000456]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.21%
—
—
—
—
—
—
0
5
211
2345
Application of cast or individual aid
SPAT1210 [2001700311]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.34%
—
—
—
—
—
—
0
8
211
2342
Ingrowing nail
L60.0 [45548199]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.22%
—
—
—
—
—
—
—
0
6
254
2669
—
Transurethral resection of prostate
KED22 [2001306138]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
0
7
275
2735
—
—
—
—
—
Ultrasound examination of uterus and uterine appendages
SPAT1181 [2001700282]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
275
2735
—
—
—
—
—
—
Fever
A03 [2002000144]
2.0e-01
—
—
—
—
—
1.1e+00
cases:2.18%
controls:1.79%
—
—
—
—
—
—
—
—
—
—
cases:4.27%
controls:1.53%
6
49
269
2693
—
—
—
—
—
9
36
202
2314
Primary total prosthetic replacement of knee joint without patellar part
NGB20 [2001308094]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.37%
—
—
—
—
—
—
—
0
10
254
2665
—
Thrombin time
3243-3 [3036489]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
0
16
211
2334
brompheniramine, combinations
R06AB51 [21603466]
6.1e-01
-1.0e+50
—
—
—
—
4.7e-01
cases:2.91%
controls:1.60%
cases:0.00%
controls:0.44%
—
—
—
—
—
—
—
—
cases:2.84%
controls:1.79%
8
44
267
2698
0
12
275
2730
—
—
—
—
6
42
205
2308
Shoulder and humerus extensive MRI examination with high intensity magnet
NB1CG [2001307237]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
275
2737
—
—
—
—
—
—
varenicline; oral
N07BA03 [21604819]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
0
7
254
2668
—
Incontinence urine
U04 [2002001139]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.22%
—
—
—
—
—
—
—
—
—
—
—
0
6
275
2736
—
—
—
—
—
Treponema pallidum Ab [Titer] in Serum by Hemagglutination
26009-1 [3019539]
—
—
—
—
—
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.19%
cases:0.00%
controls:0.30%
—
—
—
—
—
0
5
254
2670
0
7
211
2343
atorvastatin; oral
C10AA05 [21601860]
1.4e-01
9.1e-02
-1.8e-02
—
5.3e-01
1.9e-02
4.4e-02
cases:13.82%
controls:12.25%
cases:11.27%
controls:10.39%
cases:2.55%
controls:2.59%
—
—
cases:4.76%
controls:2.85%
cases:11.02%
controls:10.84%
cases:15.64%
controls:15.06%
38
336
237
2406
31
285
244
2457
7
71
268
2671
—
13
78
260
2657
28
290
226
2385
33
354
178
1996
HLA-B27 [Presence]
4821-5 [3008898]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
0
11
211
2339
Ankle and foot
ZA7.0 [2000503745]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
275
2737
—
—
—
—
—
—
Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
546-2 [3024135]
-8.5e-02
1.3e+00
—
—
—
1.9e+00
-3.7e-01
cases:2.18%
controls:2.37%
cases:2.55%
controls:0.69%
—
—
—
—
—
—
cases:2.36%
controls:0.37%
cases:2.37%
controls:3.40%
6
65
269
2677
7
19
268
2723
—
—
—
6
10
248
2665
5
80
206
2270
indometacin
C01EB03 [21600365]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.33%
—
—
—
—
—
—
cases:0.00%
controls:0.41%
—
—
—
0
9
275
2733
—
—
—
0
11
254
2664
—
Psychological sympt/compl other
P29 [2002000823]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.29%
—
—
—
—
—
—
cases:0.00%
controls:0.37%
—
—
—
0
8
275
2734
—
—
—
0
10
254
2665
—
Residual foreign body in soft tissue
M79.5 [45533938]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.21%
—
—
—
—
—
—
0
5
211
2345
Hypothyroidism, unspecified
E03.9 [45537945]
3.3e-01
—
—
—
—
—
7.5e-01
cases:1.82%
controls:1.31%
—
—
—
—
—
—
—
—
—
—
cases:4.74%
controls:2.30%
5
36
270
2706
—
—
—
—
—
10
54
201
2296
Visual disturbance other
F05 [2002000403]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.22%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.21%
0
6
275
2736
—
—
—
—
—
0
5
211
2345
Hysteroscopy
ULC02 [2001306644]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.22%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
275
2736
—
—
—
—
—
—
temazepam; oral
N05CD07 [21604642]
6.3e-01
5.2e-01
—
—
—
7.5e-01
3.3e-01
cases:6.18%
controls:3.39%
cases:3.27%
controls:1.97%
—
—
—
—
—
—
cases:4.33%
controls:2.09%
cases:5.69%
controls:4.17%
17
93
258
2649
9
54
266
2688
—
—
—
11
56
243
2619
12
98
199
2252
Chronic gingivitis
K05.18 [2000502721]
-1.0e+50
—
—
—
—
—
8.9e-01
cases:0.00%
controls:0.69%
—
—
—
—
—
—
—
—
—
—
cases:2.84%
controls:1.19%
0
19
275
2723
—
—
—
—
—
6
28
205
2322
Benign neoplasm: Colon, unspecified
D12.6 [45576377]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.33%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
275
2733
—
—
—
—
—
—
Trigger finger
M65.3 [45538828]
-1.0e+50
—
—
—
—
-1.0e+50
-1.0e+50
cases:0.00%
controls:0.36%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.30%
cases:0.00%
controls:0.64%
0
10
275
2732
—
—
—
—
0
8
254
2667
0
15
211
2335
Extraction of root of tooth
EBA30 [2001301929]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.44%
—
—
—
—
—
—
—
—
—
—
—
—
0
12
275
2730
—
—
—
—
—
—
cefaclor; oral
J01DC04 [21602886]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
0
6
211
2344
Monitoring of normal pregnancy
SPAT1196 [2001700297]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.43%
—
—
—
—
—
—
0
10
211
2340
brinzolamide
S01EC04 [21603696]
—
—
—
—
—
—
8.6e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.37%
controls:1.02%
—
—
—
—
—
—
5
24
206
2326
Change in faeces/bowel movements
D18 [2002000317]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
0
6
211
2344
Intestinal adhesions [bands] with obstruction
K56.5 [45601181]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.21%
—
—
—
—
—
—
0
5
211
2345
olanzapine; oral, parenteral
N05AH03 [21604543]
7.0e-01
—
-1.0e+50
—
-1.0e+50
—
—
cases:1.82%
controls:0.91%
—
—
cases:0.00%
controls:0.22%
—
—
cases:0.00%
controls:0.22%
—
—
—
—
5
25
270
2717
—
0
6
275
2736
—
0
6
273
2729
—
—
budesonide; oral, sublingual
A07EA06 [21600658]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.22%
—
—
—
—
—
—
—
—
—
—
—
0
6
275
2736
—
—
—
—
—
Pernicious anaemia
107 [2001600107]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.29%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
275
2734
—
—
—
—
—
—
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
X44 [45756400]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
275
2737
—
—
—
—
—
—
Bitten or struck by other mammals
W55 [45756306]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.33%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
275
2733
—
—
—
—
—
—
Influenza due to identified zoonotic or pandemic influenza virus
J09 [45755449]
-1.0e+50
-1.0e+50
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.18%
cases:0.00%
controls:0.22%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.34%
0
5
275
2737
0
6
275
2736
—
—
—
—
0
8
211
2342
Dysuria/painful urination
U01 [2002001137]
8.3e-01
-1.0e+50
—
—
—
—
-1.0e+50
cases:1.82%
controls:0.80%
cases:0.00%
controls:0.18%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.77%
5
22
270
2720
0
5
275
2737
—
—
—
—
0
18
211
2332
Hospital outpatient
ZY010 [2001311599]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.22%
—
—
—
—
—
—
—
0
6
254
2669
—
Home visit
WYA20 [2001310873]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.21%
—
—
—
—
—
—
0
5
211
2345
Obesity
E66 [45547648]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
0
7
254
2668
—
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
8070/3-C44.3 [44501067]
1.0e+50
—
—
—
—
—
—
cases:2.18%
controls:0.00%
—
—
—
—
—
—
—
—
—
—
—
—
6
0
269
2742
—
—
—
—
—
—
Polyneuropathy, unspecified
G62.9 [45566898]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.22%
—
—
—
—
—
—
—
—
—
—
—
0
6
275
2736
—
—
—
—
—
Plain photography of ocular fundus
CK2S4 [2001301455]
—
-1.0e+50
—
—
—
—
-1.0e+50
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.72%
—
0
7
275
2735
—
—
—
—
0
17
211
2333
Cardiovascular stress test using bicycle ergometer
26046004 [4094501]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.29%
—
—
—
—
—
—
—
—
—
—
—
0
8
275
2734
—
—
—
—
—
Acute and subacute iridocyclitis
H20.0 [45542994]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.51%
—
—
—
—
—
—
—
—
—
—
—
—
0
14
275
2728
—
—
—
—
—
—
Besnier prurigo
L20.0 [45562534]
—
—
—
—
—
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.19%
cases:0.00%
controls:0.68%
—
—
—
—
—
0
5
254
2670
0
16
211
2334
Retained dental root
K08.3 [45543292]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.62%
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
0
17
275
2725
0
7
275
2735
—
—
—
—
—
Erythrocytes [#/volume] in Cerebral spinal fluid
26454-9 [3027475]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
0
6
211
2344
Audiometric test
21727005 [4071702]
4.7e-01
1.1e+00
—
—
—
9.8e-01
-5.7e-03
cases:3.27%
controls:2.08%
cases:2.18%
controls:0.77%
—
—
—
—
—
—
cases:1.97%
controls:0.75%
cases:2.37%
controls:2.38%
9
57
266
2685
6
21
269
2721
—
—
—
5
20
249
2655
5
56
206
2294
Concussion
S06.0 [45582805]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.33%
—
—
—
—
—
—
cases:0.00%
controls:0.37%
—
—
—
0
9
275
2733
—
—
—
0
10
254
2665
—
Multiple sclerosis
G35 [45571794]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.18%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.19%
—
—
0
5
275
2737
—
—
—
—
0
5
254
2670
—
Polyarthrosis, unspecified
M15.9 [45543481]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.33%
—
—
—
—
—
—
—
—
—
—
—
0
9
275
2733
—
—
—
—
—

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
94
54
25.28
120.75
1.7
1.3
—
—
—
0
0
65
174
4.53
22.84
1.6
1.1
—
—
—
0
0
146
699
3.19
21.04
3.4
1.6
—
—
—
0
0
172
1026
2.66
14.77
4.8
3.7
35.20
35.90
g/l
0.89
161
952
42
112
4.22
14.56
3.9
1.4
11.76
2.66
ug/l
1.01
37
83
137
781
2.43
12.27
4.2
2.1
2.36
2.35
mmol/l
0.10
127
671
185
1220
2.43
11.73
13.2
6.0
4.15
4.21
e9/l
0.13
173
1046
159
995
2.32
11.19
2.8
2.4
—
—
estimate
—
0
0
111
623
2.27
9.82
4.8
3.8
—
—
—
0
0
61
274
2.55
8.80
2.3
1.7
—
—
—
0
0
25
67
3.99
8.54
2.1
2.5
1.27
1.63
mg/l
1.48
25
58
12
7
17.81
8.14
1.4
1.0
—
—
—
0
0
88
482
2.19
8.01
5.9
4.5
—
—
—
0
0
110
673
2.02
7.38
2.7
2.1
—
—
—
0
0
168
1193
1.97
7.30
6.8
5.2
0.17
0.20
e9/l
2.17
153
1024
161
1146
1.91
6.75
6.7
5.1
0.56
0.58
e9/l
0.40
148
959
163
1166
1.91
6.72
6.7
5.2
1.66
1.81
e9/l
0.58
152
1012
220
1747
2.07
6.59
11.7
5.6
81.76
77.37
u/l
0.64
206
1616
148
1032
1.89
6.54
6.5
5.2
8.88
8.90
%
0.03
139
954
151
1060
1.89
6.53
6.3
5.5
1.21
1.21
mmol/l
0.18
135
956
148
1033
1.88
6.51
6.4
5.1
2.77
3.13
%
0.92
139
955
95
574
1.97
6.46
1.5
1.3
—
—
—
0
0
148
1035
1.88
6.46
6.7
5.2
0.65
0.70
%
0.59
140
957
161
1157
1.88
6.44
6.8
5.1
0.04
0.04
e9/l
0.89
147
974
148
1043
1.86
6.23
6.1
5.1
60.04
57.56
%
1.46
140
985
188
1439
1.87
5.97
5.7
4.4
7.05
6.75
mmol/l
0.66
179
1359
162
1196
1.80
5.67
7.5
6.0
1.21
1.21
mmol/l
0.20
132
1040
14
26
5.60
5.29
1.3
1.7
293.64
266.47
mosm/kgh2o
2.58
14
19
37
167
2.39
5.21
3.4
2.9
1.23
1.23
mmol/l
0.09
32
138
8
6
13.66
5.11
5.8
2.2
0.62
0.59
mmol/l
—
8
6
156
1166
1.73
5.00
19.5
15.3
1.24
1.30
inr
0.78
140
966
58
323
1.99
4.85
5.1
5.0
0.98
1.02
mmol/l
0.59
53
288
8
8
10.24
4.54
1.3
1.1
—
—
—
0
0
36
174
2.22
4.34
5.3
4.5
0.69
0.80
%
0.13
13
33
77
494
1.76
4.11
3.5
2.1
2.47
2.44
mmol/l
1.61
72
430
105
735
1.67
4.08
5.6
4.8
—
—
—
0
0
99
687
1.67
3.96
4.0
3.5
7.40
7.40
ph
0.40
75
482
34
167
2.17
3.94
5.7
4.5
0.58
0.31
%
0.46
12
29
35
174
2.15
3.94
5.8
4.8
0.00
0.00
%
-0.00
12
21
8
11
7.44
3.88
1.9
2.0
1378.00
1086.64
e6/l
—
8
11
8
11
7.44
3.88
1.3
2.1
0.65
0.57
e9/l
—
8
11
134
1008
1.61
3.86
14.1
9.7
0.00
0.00
e9/l
0.50
116
819
58
349
1.83
3.81
2.1
1.8
—
—
—
0
0
8
12
6.82
3.69
5.6
2.8
1.85
4.48
nmol/l
—
8
12
33
168
2.09
3.51
5.7
4.6
0.00
0.11
%
—
10
27
8
16
5.11
3.07
1.3
1.1
—
—
—
0
0
46
277
1.79
3.01
7.1
6.5
1.93
0.98
mmol/l
0.68
37
234
5
5
10.14
2.99
2.4
1.6
72.00
122.40
e6/l
—
5
5
6
9
6.78
2.88
2.0
1.9
240.00
149.56
e6/l
—
6
9
39
229
1.81
2.77
4.1
3.6
7.38
7.35
ph
0.48
28
150
6
10
6.10
2.71
2.2
2.1
70.33
76.40
%
—
6
10
6
10
6.10
2.71
2.2
1.9
16.00
15.10
%
—
6
10
24
122
2.05
2.59
1.4
1.5
—
—
—
0
0
9
26
3.54
2.50
1.2
1.1
—
—
—
0
0
7
16
4.45
2.49
2.6
2.3
34.43
49.51
%
—
7
9
47
301
1.67
2.48
3.2
2.5
3.53
4.83
e9/l
2.27
38
253
45
285
1.69
2.47
7.2
6.4
14.89
11.43
kpa
2.26
39
278
45
285
1.69
2.47
7.2
6.4
5.49
5.12
kpa
1.20
39
277
9
27
3.41
2.41
1.2
1.2
33.72
24.32
g/l
—
9
22
7
18
3.96
2.26
1.3
1.2
—
—
—
0
0
5
9
5.63
2.22
1.0
2.0
970.00
404.22
e6/l
—
5
9
38
237
1.69
2.22
1.8
1.4
—
—
—
0
0
44
287
1.63
2.17
7.4
6.4
7.41
7.42
ph
0.25
26
163
7
19
3.75
2.16
1.0
1.2
—
—
—
0
0
26
146
1.86
2.15
1.7
1.4
—
—
—
0
0
93
718
1.43
2.10
3.4
3.3
—
—
—
0
0
5
10
5.07
2.08
1.2
1.5
2.50
4.06
mg/l
—
5
10
12
50
2.46
2.05
4.1
2.0
57.68
59.46
%
0.31
12
50
10
38
2.69
2.02
4.8
2.2
3.78
4.33
e9/l
—
10
38
28
448
0.58
1.97
1.3
1.3
98.62
37.26
iu/ml
0.35
11
134
25
411
0.57
1.95
1.3
1.3
65.64
10.57
u/ml
0.73
11
160
5
11
4.60
1.95
2.4
2.0
30.30
43.21
%
—
5
11
5
11
4.60
1.95
1.6
1.3
—
—
—
0
0
33
206
1.68
1.93
1.4
1.5
—
—
—
0
0
247
2284
1.55
1.90
24.4
14.1
30.66
23.51
mg/l
2.40
220
1834
9
34
2.70
1.88
1.7
1.4
—
—
—
0
0
6
17
3.58
1.84
1.8
1.2
—
—
—
0
0
5
12
4.22
1.83
2.8
4.4
350.00
670.33
u/ml
—
5
12
8
30
2.71
1.73
1.6
2.7
—
—
—
0
0
5
13
3.89
1.72
2.2
1.6
—
—
—
0
0
256
2398
1.58
1.72
26.3
17.9
139.28
139.85
mmol/l
2.80
250
2343
256
2400
1.57
1.69
26.3
18.0
3.99
4.00
mmol/l
0.30
251
2341
94
752
1.37
1.69
2.4
2.3
51.11
62.49
u/l
1.05
88
700
83
651
1.39
1.68
9.1
4.2
—
—
—
0
0
21
121
1.79
1.63
2.6
1.2
0.74
1.09
g/l
2.29
21
114
6
20
3.04
1.59
1.2
1.3
—
—
—
0
0
5
126
0.39
1.54
2.0
1.6
—
—
—
0
0
7
27
2.63
1.52
3.0
2.6
—
—
—
0
0
60
455
1.40
1.47
3.3
2.8
508.06
525.05
mosm/kgh2o
0.23
53
386
24
149
1.67
1.46
4.6
1.8
8.65
10.76
g/l
2.20
24
141
23
142
1.67
1.43
4.0
3.8
—
—
—
0
0
196
1775
1.32
1.41
4.3
4.3
15.02
14.95
pmol/l
0.13
169
1604
11
53
2.12
1.40
4.4
3.6
0.83
1.37
index
—
6
27
9
43
2.13
1.31
1.8
2.8
—
—
—
0
0
13
69
1.93
1.30
2.2
1.4
26.67
44.94
mg/l
2.20
13
61
13
69
1.93
1.30
2.2
1.4
20.98
32.24
mg/l
2.32
13
61
5
18
2.81
1.29
1.0
1.2
108.20
103.61
pmol/l
—
5
18
38
515
0.70
1.26
1.3
1.3
0.75
1.82
u/ml
1.08
11
126
69
550
1.33
1.25
2.9
2.4
4.50
6.12
e6/l
0.74
61
493
41
300
1.43
1.23
1.4
1.4
—
—
—
0
0
6
26
2.33
1.19
1.0
1.1
—
—
—
0
0
6
26
2.33
1.19
1.0
1.1
—
—
—
0
0
6
26
2.33
1.19
8.0
1.8
4.75
-0.47
mmol/l
—
6
26
6
26
2.33
1.19
1.0
1.1
—
—
—
0
0
6
26
2.33
1.19
1.0
1.1
—
—
—
0
0
250
2371
1.39
1.15
20.4
12.9
—
—
—
0
0
38
280
1.41
1.11
1.6
1.6
—
—
—
0
0
123
1072
1.26
1.11
2.9
2.5
78.12
78.27
nmol/l
0.02
113
948
93
784
1.27
1.11
3.7
3.2
33.43
139.88
e6/l
0.68
76
595
255
2432
1.40
1.08
15.3
10.4
24.47
25.61
u/l
0.75
241
2334
257
2455
1.41
1.07
30.7
19.2
78.86
80.32
umol/l
0.43
252
2416
89
1042
0.79
1.06
1.7
2.0
1.47
1.32
mmol/l
1.01
70
872
5
22
2.29
1.04
2.4
1.2
31.80
34.09
pg
—
5
22
8
143
0.55
0.96
1.0
1.4
—
34.57
—
0
15
29
211
1.42
0.93
9.1
7.4
—
—
—
0
0
229
2176
1.25
0.80
5.4
5.3
2.15
1.94
mu/l
1.20
204
1978
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
10
161
0.61
0.78
2.3
2.6
—
12.81
—
0
9
6
34
1.78
0.76
1.0
1.1
—
—
—
0
0
0
28
0.00
0.76
0.0
1.0
—
320.55
—
0
20
7
38
1.86
0.74
1.0
1.1
—
—
—
0
0
7
38
1.86
0.74
1.0
1.1
—
—
—
0
0
5
25
2.02
0.73
2.6
3.1
—
—
—
0
0
119
1071
1.19
0.72
4.4
4.0
56.26
41.07
ng/l
0.40
98
800
76
656
1.21
0.72
3.9
3.0
0.25
0.41
e6/l
0.83
61
470
258
2494
1.31
0.72
34.8
21.7
243.62
244.32
e9/l
0.06
252
2435
258
2494
1.31
0.72
34.6
21.6
91.19
91.31
fl
0.16
253
2457
15
101
1.51
0.71
1.5
1.6
2.22
1.57
g/l
—
10
93
258
2495
1.31
0.71
35.3
22.0
39.39
40.65
%
2.94
253
2458
258
2495
1.31
0.71
34.8
21.7
6.65
6.68
e9/l
0.08
252
2428
258
2495
1.31
0.71
34.6
21.6
30.19
30.41
pg
1.15
253
2458
258
2495
1.31
0.71
34.7
21.6
4.38
4.52
e12/l
3.65
250
2426
258
2496
1.30
0.70
34.9
21.8
131.25
136.52
g/l
5.97
253
2458
5
27
1.87
0.68
2.2
1.5
93.62
90.02
%
—
5
27
26
198
1.34
0.67
3.2
4.0
82.40
85.13
ng/l
0.09
20
169
71
614
1.21
0.66
3.5
3.0
—
0.00
estimate
—
0
6
5
29
1.74
0.64
1.2
1.1
1.49
1.52
g/l
—
5
24
98
876
1.18
0.64
4.4
3.8
83.46
111.03
e6/l
0.31
76
607
73
636
1.20
0.63
2.8
2.4
336.39
359.22
umol/l
1.26
67
556
80
704
1.19
0.62
5.6
4.0
0.00
0.00
estimate
-0.00
29
222
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
10
65
1.56
0.56
1.0
1.1
—
—
—
0
0
6
40
1.51
0.52
2.0
1.4
—
—
—
0
0
28
229
1.25
0.46
2.6
2.0
0.00
0.00
estimate
—
5
53
17
219
0.76
0.45
1.2
1.4
—
—
—
0
0
12
86
1.41
0.45
2.1
2.0
203.75
363.70
ug/l
0.74
12
79
44
380
1.19
0.43
3.7
3.0
1.66
2.28
e6/l
0.28
27
177
15
113
1.35
0.43
2.6
2.2
0.00
0.00
estimate
—
5
36
16
122
1.33
0.43
5.9
3.3
—
—
—
0
0
77
846
0.88
0.42
3.2
3.6
—
—
—
0
0
5
33
1.52
0.41
1.0
1.0
—
—
—
0
0
0
17
0.00
0.41
0.0
1.1
—
0.48
—
0
11
0
17
0.00
0.41
0.0
1.6
—
—
—
0
0
9
67
1.35
0.38
2.9
3.6
—
—
—
0
0
5
79
0.63
0.36
2.0
2.0
—
—
—
0
0
9
123
0.72
0.36
2.4
2.5
—
—
—
0
0
88
949
0.90
0.35
3.6
3.6
40.98
42.87
mg/l
0.05
58
609
52
578
0.88
0.34
5.5
4.2
1.02
1.02
kg/l
0.46
35
382
160
1529
1.10
0.33
3.4
3.2
58.72
47.25
u/l
0.69
150
1428
14
176
0.79
0.33
1.0
1.2
—
—
—
0
0
92
986
0.90
0.32
3.6
3.4
7.41
7.66
mmol/l
0.25
76
833
28
240
1.18
0.31
1.2
1.3
—
—
—
0
0
72
780
0.90
0.31
2.1
1.7
19.60
20.41
nmol/l
0.15
54
650
7
54
1.30
0.30
1.3
1.3
21.69
27.20
iu/l
—
7
44
23
270
0.84
0.30
3.0
2.2
110.67
139.57
ug/g
0.37
18
205
20
169
1.20
0.26
8.3
3.5
—
—
—
0
0
15
181
0.82
0.26
2.4
2.6
122.60
131.02
g/l
0.79
15
175
107
1014
1.09
0.26
4.3
3.5
6.28
6.21
ph
0.24
58
568
100
947
1.09
0.24
4.9
3.9
0.00
0.00
estimate
-0.00
24
188
43
390
1.12
0.24
2.6
1.8
29.80
29.18
s
0.25
43
379
88
930
0.92
0.23
5.0
4.2
2.02
1.95
ug/l
0.12
75
817
5
39
1.29
0.23
1.4
1.2
—
—
—
0
0
25
220
1.15
0.22
3.4
2.4
0.12
0.36
e6/l
1.86
25
207
115
1200
0.93
0.21
2.4
2.1
91.10
96.60
pmol/l
0.53
56
605
0
11
0.00
0.21
0.0
10.3
—
0.63
—
0
11
0
11
0.00
0.21
0.0
16.6
—
974.82
—
0
11
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
70
658
1.08
0.20
4.5
3.4
0.00
0.00
estimate
-0.00
27
183
6
49
1.23
0.20
1.0
1.8
30.67
33.80
umol/l
—
6
44
55
513
1.09
0.19
4.3
4.3
25.92
262.55
ng/l
2.19
46
419
131
1267
1.06
0.17
4.9
4.0
0.00
0.00
estimate
-0.00
30
242
30
274
1.11
0.16
2.7
3.0
2.03
1.95
mmol/l
0.03
24
231
17
151
1.13
0.13
1.1
1.2
119.94
327.58
u/ml
1.06
17
143
9
106
0.84
0.13
5.2
3.2
0.97
0.90
%
—
9
101
62
593
1.06
0.12
4.2
3.8
—
0.00
—
0
7
30
279
1.08
0.11
2.6
3.1
7.38
7.39
ph
0.27
19
167
228
2306
0.95
0.11
5.1
5.6
6.04
6.06
mmol/l
0.09
201
2089
51
535
0.94
0.11
2.2
1.7
1.58
1.12
mg/l
0.50
40
416
219
2215
0.95
0.10
4.3
4.6
1.32
1.27
mmol/l
0.49
193
2012
95
977
0.96
0.10
4.7
4.2
5.45
7.26
mg/mmol
0.41
63
614
13
116
1.13
0.09
1.2
1.3
—
—
—
0
0
228
2302
0.96
0.09
4.9
5.5
1.44
1.46
mmol/l
0.39
204
2112
56
539
1.05
0.08
1.6
1.8
460.25
26292563.93
pmol/l
0.50
44
445
18
195
0.92
0.08
1.9
2.7
6.18
6.00
ph
0.33
11
133
10
88
1.14
0.08
21.2
7.9
—
—
—
0
0
10
88
1.14
0.08
1.1
1.3
—
—
—
0
0
225
2271
0.96
0.08
6.8
7.3
40.36
39.92
mmol/mol
0.29
197
2113
8
74
1.08
0.07
2.3
1.7
—
—
—
0
0
230
2318
0.96
0.06
4.8
5.6
4.64
4.55
mmol/l
0.61
205
2133
32
305
1.06
0.06
1.3
1.3
415.00
508.35
titre
—
8
79
16
172
0.93
0.06
1.8
1.4
—
—
—
0
0
44
426
1.04
0.05
2.0
1.2
1.92
2.62
g/l
3.28
33
239
127
1253
1.02
0.05
4.9
4.0
0.00
0.00
estimate
-0.00
29
239
129
1278
1.02
0.03
5.0
4.0
0.00
0.00
estimate
-0.00
29
224
11
118
0.93
0.03
1.0
1.1
—
—
—
0
0
46
451
1.02
0.02
2.0
1.8
1189.54
1219.81
nmol/l
0.07
32
336
104
1050
0.99
0.02
3.4
3.0
161.04
120.47
ug/l
0.79
90
975
52
522
1.00
0.00
2.4
2.8
0.72
0.76
ug/l
0.19
38
324
34
341
1.00
0.00
1.4
1.2
—
—
—
0
0
16
157
1.02
0.00
1.3
1.3
—
—
—
0
0
62
617
1.01
0.00
2.3
2.3
3.19
2.80
mg/l
0.33
47
518
12
125
0.96
0.00
1.7
1.9
—
—
—
0
0
236
2356
1.01
0.00
5.5
6.5
2.70
2.64
mmol/l
0.37
210
2168
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
1.91
—
0
5
0
8
0.00
-0.00
0.0
5.5
—
24.94
—
0
8
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
6.2
—
6.32
—
0
6
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
8.0
—
7.60
—
0
6
5
50
1.00
-0.00
1.0
1.5
—
—
—
0
0
5
59
0.84
-0.00
2.2
1.8
112.00
131.45
g/l
—
5
46
7
77
0.91
-0.00
1.4
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
26.67
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
2.17
—
0
6
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
78.60
—
0
5
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_SALIVARYNAS_WIDE – Malignant neoplasm of other and unspecified major salivary glands, including Hilmo

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).